Podcasts about GLP

2024 was filled with upswings and downswings in the healthcare industry. Whether it was unprecedented cyberattacks, the continued rise of GLP-1 therapies, or the return of hospital volumes, healthcare leaders stayed busy. And things aren't expected to slow down in 2025. To give you a preview of where we may be headed, this week, hosts Rachel (Rae) Woods and Abby Burns invite five Advisory Board experts to break down what their teams will be researching in 2025 and why these topics matter for health leaders. Throughout the episode, our experts preview how health system service lines, value-based care, care variation reduction, artificial intelligence, and specialty pharmacy will change in 2025 and beyond. Links: The state of the industry: What healthcare leaders need to know for 2025 Get early access to our 2025 executive briefing Service lines and specialty care landing page Value-based care landing page Artificial intelligence landing page Hospital and health system trends landing page 4 common pitfalls in care standardization — and how to overcome them Learn more about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

Here's the updated YouTube description that includes the newest OSLP episode mention:

Since we're a couple of weeks into the new year, I want to dive into a topic that I believe will really resonate with you - especially if you're just starting your fitness journey!I'm 15 years into my fitness journey; what I'm doing now looks pretty different compared to what I was doing at the beginning. I've learned a lot along the way, so I want to share the steps I would take if I was starting my fitness journey in 2025.One of the MOST crucial pieces to set you up for success is building a solid foundation. A strong foundation is essential to your long-term fitness success. While it can take some time to set this up, it will pay off weeks, months, and years down the road! When it comes to your workouts, your nutrition, water intake, and more, ALL of these habits should be simple and sustainable. Give yourself time to implement these into your life, and stay away from the quick fixes and detoxes that are EVERYWHERE this time of year (those aren't doing you any favors - I promise)!Ultimately, I want you to understand (and truly believe) that you CAN see progress on your fitness journey. This work isn't something you're doing for a 30 or 90 day challenge; these are habits you're creating for LIFE, so let's get you there!In this episode, we cover:Why it's vital that you have a solid foundation when starting your fitness journeyUtilizing a workout program that includes weightlifting & mobility/flexibilityTracking what you're eating into MyFitnessPalFocusing on more walking + waterWhat you can hone in on & personalize once your foundation (all of the above) is in shapeMy best advice for navigating all of the quick fixes, sugar detoxes, GLP-1s, and more this time of yearLinks/Resources:Ep. 135 | The Power of Inner Work: How Therapy Transforms Your Body Image, Fitness Journey, and More with Erin Burns (Part 1)Ep. 136 | Overcoming Anxiety and Embracing Compassion on Your Fitness Journey with Erin Burns (Part 2)Listen to Sol Fit podcastJoin FIT CLUB, my monthly membership with workouts you can do at home or the gymPRIVATE COACHING is my 1:1 program (choose 3 or 6 month option)Connect with me on Instagram @kristycastillofit and @unfuckyourfitnesspodcast so we can keep this conversation going-be sure to tag me in your posts and stories!Join my FREE Facebook group, Unf*ck Your FitnessClick HERE for my favorite fitness & life things!

In this episode, we delve into The Telepathy Tapes and other telepathy theories. From the CIA's long-standing obsession with telepathy and psychic phenomena to the uncanny ways animals might use telepathy to communicate, we explore the science, myths, and mysteries behind this phenomenon. Join us as we speculate on what telepathy could mean for humanity, whether it's a lost ancient skill, an untapped superpower, or just a fun conspiracy theory to ponder. Head to Squarespace.com/fluently for a free trial, and when you're ready to launch, use code FLUENTLY to save 10% off your first purchase of a website or domain. Treat yourself this winter without the luxury price tag. Go to Quince.com/fluently for 365-day returns, plus free shipping on your order! Now's your chance to change the way you sleep with Boll & Branch. Get 15% off, plus free shipping on your first set of sheets at BollAndBranch.com/fluently to save 15%. Ro provides access to the most popular weight loss shots on the market. Average weight loss is 15-20% in 1 year, with healthy lifestyle changes. BMI and other eligibility criteria apply. Go to ro.co/fluently to see if your insurance covers GLP-1s—for free!

The first 45 minutes of this conversation are FREE! Listen to the extended version of this episode when you subscribe to Patreon here. Dr. Mara Gordon joins the pod to share what it means to be a size-inclusive physician and why it's time to rethink weight in medicine. We discuss why it's harmful to center medical care on a patient's weight, the stigma and negative health consequences of medical providers prescribing intentional weight loss, how to advocate for yourself with your physician, declining to be weighed at the doctor's, why BMI is so problematic, caring for and treating diagnoses without weight loss, and her thoughts on the GLP-1 hype. Mara also opens up about what she regrets as a physician prior to finding fat-positive medicine, and how she came to see the harms of anti-fat bias and diet culture more broadly.  In the EXTENDED version (a bonus episode that you can find at www.patreon.com/fullplate), Mara answers questions about: her concerns about GLP-1s like Ozempic, and what we can do to think about them differently how larger bodied humans can advocate for themselves at the doctor's office without giving the unwritten message that they're “noncompliant” or don't care about their health how to deal with being told weight loss will help a specific health condition (like diabetes, joint pain, sleep apnea) why folks in larger bodies need to receive the same treatments offered to thin-bodied folks how “obesity” as a pathological condition has its roots in the pharmaceutical industry, and it started in the 90s   More about Dr. Mara Gordon: Dr. Gordon is a family physician and writer based in Philadelphia. She worked in public health in Tanzania and Malawi before returning to the Philadelphia area to attend medical school at the Perelman School of Medicine at the  University of Pennsylvania, where she was awarded the Zervanos Family Medicine Award for a medical student going into family medicine. She cares for patients of all ages at the Cooper Family Medicine office at the Kroc Center in Camden. She loves working with medical students in preclinical and clinical educational settings. She teaches selectives in Narrative Medicine and Audio Storytelling and co-directs the Narrative Medicine Scholarly Concentration. She continues to write professionally about issues in contemporary medicine. Learn more about her here.    Check out Medical Students for Size Inclusivity here.  You can read more of Mara's work here: maragordonmd.com Here's more about AWSIM: www.weightinclusivemedicine.org Support the show on Patreon: Enjoying this podcast? Please support the show on Patreon for bonus episodes, community engagement, and access to "Ask Abbie" at Patreon.com/fullplate Join the Full Plate Patreon right here! Group program: Good news! Enrollment is open for Abbie's next group program: Looking for more support and concrete steps to take to heal your relationship with food and your body? Apply for Abbie's next 10-week group program: https://www.abbieattwoodwellness.com/group-coaching Group membership: Already been at this anti-diet culture thing for a while, but want community and continued learning? Apply for Abbie's monthly membership: https://www.abbieattwoodwellness.com/circle-monthly-group Social media: Find the show on Instagram: @fullplate.podcast Find Abbie on Instagram: @abbieattwoodwellness Podcast Cover Photography by Anya McInroy Podcast Administrative Support by Alexis Eades Podcast Editing by Brian Walters This podcast is ad-free and support comes from our Patrons on Patreon: Patreon.com/fullplate

Subscriber-only episodeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55If You are having issues accessing Paid Subscriber content please send an email to support@buzzsprout.com and a member of Buzzsprout's technical team will help you access the content.______________________________________________________________________Part 1In this episode, we delve into the complex world of insulin resistance, exploring its impact on hunger, weight management, and overall health. We'll uncover the science behind this metabolic condition and discuss how it can lead to continued obesity and inflammation. We'll also challenge the traditional diet culture narrative, examining why it often leads to a cycle of yo-yo dieting. We'll explore the role of hormones, particularly GLP-1, in regulating appetite and blood sugar levels, and how GLP-1 therapies can be a valuable tool in managing insulin resistance.We chat about menopause and perimenopause and the evolution of hormone replacement therapy. We also explore the limitations of BMI, and introduce the Body Roundness Index as a more accurate measure of body composition. Join us as we unravel the complexities of obesity management, hormone health, and personalized approaches to well-being.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy  Kim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

In this episode of the Fix SLP podcast, Dr. Jeanette Benigas and Elizabeth Nielsen, MA/SLP, are joined by Jessica, a parent and advocate, to discuss Gestalt Language Processing (GLP) and its impact on autistic individuals. The conversation highlights the transformative nature of GLP, the challenges families face in accessing meaningful support, and the systemic barriers posed by outdated practices in speech-language pathology. Jessica shares her concerns about a controversial ASHA convention presentation that disparaged GLP. Jessica reached out to ASHA to share her perspective as a parent, emphasizing the life-changing outcomes of GLP for her child and raising concerns about ASHA's dismissive response to advocacy efforts from families and clinicians alike. The conversation emphasizes the need for ASHA to address these issues and better support SLPs and their clients.The three examine ASHA's role in perpetuating these challenges by failing to prioritize evidence-based practices and the lived experiences of clinicians, families, and autistic individuals. They critique the exclusion of GLP from ASHA's Practice Portal and explore the broader implications for professional transparency, autonomy, and accountability.This episode underscores the need for modernization in the field and calls for grassroots advocacy to ensure clinicians and families have access to diverse, evidence-informed approaches. It's a candid discussion that reflects Fix SLP's mission to challenge the status quo and push for meaningful change in speech-language pathology.Listeners are encouraged to engage with the movement by sharing the episode, submitting feedback to ASHA's board, and supporting sustained advocacy for a more inclusive and equitable future in the field.Want to lead or join your state team? Email your name and state to states@fixslp.com.Set up a FREE account to begin using the CU tracker.Want to earn some PDHs or CEUs? Use code FIXSLP58 to get a $20 discount coupon off any subscription!Become a sustaining partner.Follow us on Instagram.Find all our information at fixslp.com and sign up for our email list to be alerted to new episodes and content.Email us at team@fixslp.com.Leave a message on our Minivan Meltdown line! ★ Support this podcast ★

In this episode of Founder's Club, sponsored by LifeRx.md, we sit down with Felipe Rose, the iconic "Indian Chief" of the Village People, for an inspiring conversation about health, transformation, and second chances. Felipe opens up about his life as a disco legend, the challenges of maintaining his health in the demanding entertainment industry, and how his lifestyle took a toll during the pandemic.Felipe shares how LifeRx.md, a GLP-1 telehealth company specializing in weight loss and wellness, helped him regain control of his health and happiness. From curbing cravings to providing personalized support and guidance, Felipe credits the program with transforming not only his body but also his mindset. At 70 years old, he's living a healthier, more balanced life and inspiring others to prioritize their well-being.Tune in for an honest and uplifting discussion about reinvention, resilience, and the power of making meaningful lifestyle changes.

Episode 29: In this enlightening episode of Former Fat Friend, we welcome the esteemed Dr. Eric Smith, a pioneer in bariatric and robotic surgery. With a career spanning nearly two decades, Dr. Smith shares his profound insights into the evolution of obesity medicine and the transformative impact of bariatric surgery. As the Chief of Surgery at Georgetown Community Hospital and Medical Director of the Kentucky Bariatric Institute, Dr. Smith has performed over 5,000 robotic cases, making him a leader in the field. He is also known for his role on the TLC show 1000 Pound Sisters and as co-host of the Pop Culture podcast. Join us as Dr. Smith delves into his journey from training in Dayton, Ohio, to becoming a prominent figure in obesity treatment. He discusses the challenges and breakthroughs in bariatric surgery, the significance of patient trust and support, and the critical role of mental health in achieving successful outcomes. Dr. Smith also sheds light on the misconceptions surrounding bariatric surgery, the importance of muscle maintenance for long-term weight loss, and the potential of GLP-1 medications. This episode offers a comprehensive look at the future of bariatric surgery and obesity medicine, highlighting the need for a multifaceted approach to treating obesity. Dr. Smith's dedication to patient care and his innovative work with Pop Recovery Systems exemplify his commitment to improving health outcomes for those struggling with obesity. Tune in for a thought-provoking conversation that challenges traditional views and inspires hope for a healthier future. Learn more about the work Dr Smith is doing here: https://kentuckybariatricinstitute.com  Learn more about Pop Recovery Systems here: https://www.poprecoverysystems.com  Listen to the Pop Culture podcast here: https://podcasts.apple.com/us/podcast/pop-culture-podcast/id1775983707    Follow us on social media: @FormerFatFriendPod @MaintainingKasey    

In this week's episode, Han is joined by Zuzanna Gajowiec. Zuzanna is a Clinical Psychologist, Family Therapist, and Ireland's first Certified Eating Disorder Specialist and Consultant (CEDS-C). With over a decade of experience, Zuzanna is dedicated to supporting individuals and families on their journey to recovery, focusing on physical healing, body image, and family connections.As the IAEDP Chapter Chair of Ireland and Clinical Lead at a Residential Eating Disorder Treatment Centre, Zuzanna also teaches, consults, and supervises other therapists, sharing her expertise to advance the understanding of eating disorders.This week, we discuss:The science behind GLP-1 and how they work in the body.The impact of GLP-1s being presented as a safe, miracle drug.The difference in dosage and use for diabetes and weight loss, and the lack of research.The side effects of misuse of GLP-1 medications.How GLP-1 medications can implicate ED treatment and impact recovery.The importance of health care professionals understanding GLP-1 medications.The attraction of quick fixes as opposed to difficult therapy and how we navigate this.Zuzanna mentioned a few resources in the podcast, and you can find them here:GLP-1 research in ED populationsRagen Chastain's narrative on GLP-1 medicationsRagen Chastain's Substack To find out more about Zuzanna, you can connect with her in the following places:Instagram - @supported_familiesWebsite - https://supportedfamilies.ie/LinkedIn – Zuzanna GajowiecPlease note that this podcast explores topics some individuals may find difficult to hear and should not be used as a replacement for professional advice. If you need further support after this podcast, please consider talking to someone you trust. You may also wish to reach out to your GP or mental health professional.We've included a list of additional support options in case you need them:Samaritans are here for whatever you are going through. You can call free any time, from any phone, on 116 123.FirstSteps Eating Disorders is an eating disorders charity for children and their families, young people, and adults affected by eating difficulties and disorders. You can call them on or email info@firststepsed.co.uk.Beat Eating Disorders is an eating disorder charity offering support for those with or supporting someone with an eating disorder. You can call their helpline for free on 0808 801 0677 (England), 0808 801 0432 (Scotland), 0808 801 0433 (Wales), 0808 801 0434 (Northern Ireland).

Den Vorstoss hatten Vertreterinnen und Vertreter von SP, Grüne/Junge Grüne und der GLP eingereicht. Nach Ansicht der Motionärinnen und Motionäre solle der Einbürgerungsprozess «erleichtert» werden. Weiter in der Sendung: · Der Zuger alt Ständerat Rolf Schweiger ist gestorben.

Diese Woche sorgte der Wechsel von FDP-Nationalrat Matthias Jauslin zur GLP für Schlagzeilen. Umweltfragen hätten bei der Partei keinen Platz mehr. Stimmt das? Das Echo-Gespräch mit dem Politologen Georg Lutz von der Universität Lausanne. Alle Themen: (00:00) Intro und Schlagzeilen (01:29) Nachrichtenübersicht (06:41) Wie wichtig sind Umweltthemen noch für die FDP? (12:57) Viele Spitäler sind in wirtschaftlicher Schieflage, doch es geht auch anders (17:57) Der mächtigste Berater von Präsident Selenski (23:19) Der Spielraum für Karikaturisten wird enger - nicht nur in den USA

On this week's episode of "The Diet Obsessed Podcast" in my regular segments I disuss my exciting Ninja Creami purchase, how Sami from Betches that used to host Diet Starts Tomorrow is now on GLP-1's and she's talking about it, a new ant-aging procedure called Ellacor I am investigating and so much more!For my podcast review, I review another episode of "The Drive" from Dr. Peter Attia, where he discusses whether there is a "Best" diet and how he is sick of cultish buffoonery around nutrition.If these topics interest you, please subscribe to "Craving More" or "Craving More VIP" premium content through this link:https://linktr.ee/thedietobsessedpodcast and don't forget to leave a rating + review!To get 20% off Prolon Products, visit this link: https://prolonfast.com/products/gofast?rfsn=7643165.a5521d&utm_source=refersion&utm_medium=affiliate&utm_campaign=7643165.a5521d and use code: VERONICA20 at checkout.Finally, follow me on Instagram @thedietobsessedpodcast @veronica.santarelli and @cannabinoidactivist Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

Mind Pump Fit Tip: The top 5 nutrition mistakes of 2025. (2:12) Probiotics and skin health. (27:10) Growing pains. (30:35) The spark of life. (34:03) The body keeps the score. (36:50) Exercise and its effect on your mortality rate. (42:39) Remaining positive on the GLP-1 craze. (46:48) The newest Ozempic trend. (48:36) Rotten Tomatoes gauge for a good movie. (49:55) #ListenerLive question #1 – Is my lifting workout enough activity for the day or do I need to add cardio? (59:40) #ListenerLive question #2 – I'd like to decrease the muscularity of my arms and shoulders without significantly losing strength because I still need to be strong for my day job. Is that possible? (1:09:01) #ListenerLive question #3 – How should you train if you keep hurting your knees? (1:23:04) Related Links/Products Mentioned Ask a question to Mind Pump, live! Email: live@mindpumpmedia.com Visit Seed for an exclusive offer for Mind Pump listeners! **Promo code 25MINDPUMP at checkout for 25% off your first month's supply of Seed's DS-01® Daily Synbiotic** Visit Rock Recovery Center for the exclusive offer for Mind Pump listeners! ** Enter to win a $60K scholarship!  By filling out the form and scheduling your call, you'll also be entered for a chance to win a free 60-day scholarship at Rock Recovery Center, their premier treatment center in West Palm Beach, Florida. You don't want to miss this opportunity, so act fast! ** January Promotion: New Year's Resolutions Special Offers (New to Weightlifting Bundle | Body Transformation Bundle | New Year Extreme Intensity Bundle | Body Transformation Bundle 2.0  ** Savings up to $350! ** Mind Pump #2437: What Happens to Your Body When You Quit Ultra-Processed Foods for 30 Days Mind Pump #2160: Macro Counting Master Class How to Get the Best Benefit From Probiotics for Skin Health The effect of probiotics on immune regulation, acne, and photoaging Scientists Just Captured The Flash of Light That Sparks When a Sperm Meets an Egg Mind Pump #2392: Steps to Overcoming Addiction with Tom Conrad & Ben Bueno UPDATE: Fitness Still Matters to Reduce all-Cause and Heart Disease Deaths, Despite Advances in Modern Medicine and Lifestyle Changes Building Muscle with Adam Schafer – Mind Pump TV Jupiter Ascending (2015) - IMDb The Later Daters Season 1 Docuseries Cast & Release Date – Netflix Train the Trainer Webinar Series Get your free Sample Pack with any “drink mix” purchase! Also try the new LMNT Sparkling — a bold, 16-ounce can of sparkling electrolyte water: Visit DrinkLMNT.com/MindPump Personal Trainer Growth Secrets | Powered by Mind Pump Mind Pump #2382: The 5 Biggest Challenges With Cutting & Bulking Mind Pump #2490: Improve Your Muscle, Strength & Athleticism in Only 15 Minutes a Day Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Thomas Conrad (@realrecoverytalktom) Instagram Christina Hathaway (@mindsetofmattercoaching) Instagram Arthur Brooks (@arthurcbrooks) Instagram  

Sometimes your willpower seems pretty good but other times - especially right when you need it – it disappears. What if there was a way to boost your will power right when you need it most? This episode begins with a technique that can help you resist whatever that temptation when it is right in front of you. https://www.scientificamerican.com/podcast/episode/clenched-muscles-assist-self-contro-10-10-20/ When you think about it, being happy isn't something you do. Happiness is the result of something you enjoy. In other words, you must do something fun first, then happiness will follow. This is according to Mike Rucker, an educational psychologist and the author of a book called The Fun Habit (https://amzn.to/3inKGPT). Listen as Mike reveals why fun is the key to real happiness. And he explains how it only takes a little fun to create a significant increase in your happiness level. Listen as Mike offers some simple strategies to make time for fun and why it is essential to do so.  Having reliable electricity at the flip of a switch is something we all expect. Yet it's only been in the last 120 years or so that electricity has been in most homes. When you think about how much electricity has transformed our lives, it is really quite amazing. So how did science figure out how to tame this force of nature and harness it so it powers so much of our lives today? That is a story Kathy Joseph is here to tell. She holds advanced degrees in physics and engineering and has a YouTube Channel called Kathy Loves Physics and History (https://www.youtube.com/c/KathyLovesPhysicsHistory). She is also author of the book The Lightning Tamers: True Stories of the Dreamers and Schemers Who Harnessed Electricity and Transformed Our World (https://amzn.to/3CqcyJY) Whenever you feel down or depressed, it is usually because you are regretting something in your past or you worrying about something that may happen in your future – or it could be both. Listen as I reveal what you can do the next time that happens which may make you feel better in the moment. Source: Dr. Jeffrey Rossman author of The Mind-Body Solution (https://amzn.to/3QkommK) PLEASE SUPPORT OUR SPONSORS!!! SHOPIFY:  "Established in 2025". Has a nice ring to it, doesn't it? Sign up for a $1 per-month trial period at https://Shopify.com/sysk . Go to SHOPIFY.com/sysk to grow your business! HERS: Hers is changing women's healthcare by providing access to GLP-1 weekly injections with the same active ingredient as Ozempic and Wegovy, as well as oral medication kits. Start your free online visit today at https://forhers.com/sysk Learn more about your ad choices. Visit megaphone.fm/adchoices

How can GLP-1s like Ozempic truly transform weight management and wellness—and what makes them so controversial? Dr. Gus Vickery, who specializes in total body and mind optimization, dives deep into how these groundbreaking treatments are revolutionizing weight management, nutrition, and even menopause. Why are they causing such a stir, and are they truly the game-changers they claim to be?   Join us as we explore the intricate relationship between GLP-1 therapy and nutritional sufficiency. Can optimizing your diet really help reduce medication dosages? What role do protein intake and exercise play in preserving muscle mass during weight loss? Dr. Vickery unravels these mysteries and more.   The challenges of menopause, particularly weight gain, are also on the table. How can GLP-1 receptor agonists assist in managing hormonal shifts and inflammation? Are these medications the key to achieving sustainable health and wellness for women in midlife?   In this episode, we uncover: How GLP-1 medications can revolutionize your weight management strategy. Why nutritional sufficiency is crucial for reducing medication dosages. How to optimize protein intake and exercise to preserve muscle mass. The impact of GLP-1 therapy on menopause-related weight gain and hormonal balance. How to support digestive health and nutrient absorption through enzymes, mindfulness, and supplements.   Tune in to uncover the secrets to achieving a balanced, healthy lifestyle. Dr. Vickery's insights will leave you informed and inspired to take charge of your health journey. Don't miss this enlightening episode!   Visit Dr. Gus Vickery's website.   Products mentioned Kion aminos for your essential amino acid intake while on GLP1s. Get 10% off here.   Sponsors Timeline is offering 33% off your first order of Mitopure. Go to timeline.com/hormone33 and get 33% off your order.   Mitolux: Get 10% off your UVB VItamin D Red Light Mitolux Box here with coupon code KM10!   Are you in peri or post menopause and looking to optimize your hormones and health? At Hormone Solutions, we offer telemedicine services and can prescribe in every U.S. state, as well as in British Columbia, Alberta, and Ontario in Canada.   Visit karenmartel.com to explore our comprehensive programs: Bioidentical Hormone Replacement Therapy Individualized Weight Loss Programs  Peptide Therapy for weight loss    Interested in our NEW Peptide Weight Loss Program? Join today and get all the details here.   Join our Women's Peri and Post Menopause Group Coaching Program, OnTrack, TODAY!   To our nursing audience members, our podcasts qualify for nursing CE @ RNegade.pro. Provide # CEP17654.   Your host: Karen Martel Certified Hormone Specialist, Transformational Nutrition Coach, & Weight Loss Expert   Karen's Facebook Karen's Instagram

This week, we're joined by Robin, our Holistic Integration Nutritionist, to talk about the dangers of Ozempic-style drugs and how they can harm patients long-term.  In this episode, find out:—How Ozempic-style drugs work by trying to imitate the GLP-1 hormone the body produces naturally.  And why these drugs don't work as well as the actual GLP-1 hormone because they are not the exact hormone, but something called "an agonist" which can produce the OPPOSITE effect intended. —Why Fiber has been consistently shown to be the best thing for weight loss. —The story behind how a Type-II Diabetes drug transformed into being marketed as a weight loss drug.  And the role of celebrity influencers in marketing these drugs with unrealistic expectations.—The dangerous side-effects being experienced from Ozempic-like drugs, including gastric and abdominal issues that have caused stomach paralysis where people "will never be able to eat normally again".  And how patients have also experienced pancreatitis, nervous system damage, blindness, kidney failure, and even suicidal thoughts.—Why Dr. Prather says that quick weight loss is never just about losing fat, but a loss of muscle.  And why this explains "Ozempic face" and "Ozempic butt". —How Holistic Integration is able to get to the root cause of obesity through advanced diagnostics like our Gut Zoomer.  And the detailed information about your body that is revealed through stool kit testing.—Why Dr. Prather says that "people who take their health seriously" should have a Functional Health Doctor.—How the Body Composition Analysis and Fit3D Body Scan diagnostics used at Holistic Information show a detailed and accurate picture of your body. —How you can get a 20% discount on all advanced diagnostics at Holistic Integration for the month of January.—Plus, we announce the details of our Free Holistic Integration "Fit Focus" seminar on January 29th at 6 p.m.http://www.TheVoiceOfHealthRadio.com

In this insightful episode, I sit down with Dr. Charles Cavo to explore the growing use of GLP-1 receptor agonists like Ozempic and dive into their benefits and considerations in metabolic treatments. Dr. Cavo shares valuable insights from his work at the metabolic center in Connecticut, explaining the complexities of modern weight management medications and why lifestyle integration is essential for achieving sustainable results. He makes a strong case for the power of personalized healthcare strategies and the broader metabolic advantages of these treatments—especially in preventing dementia and reducing chronic disease risk. We also explore natural ways to enhance GLP-1 production, including supplements like allulose, berberine, and green tea extract, along with exercise and dietary adjustments. Dr. Cavo takes us through the importance of hormone replacement therapy (HRT) for women's health, debunking myths and clarifying its role. He also discusses pregnancy and menopause, emphasizing how tailored medical care is key to navigating these transitions. This episode is packed with essential insights, blending conventional and holistic approaches to help you optimize your health. Key Takeaways: GLP-1 receptor agonists are transformative in addressing metabolic dysfunction but must be paired with lifestyle changes for effective, lasting results. Hormone Replacement Therapy (HRT) is crucial for mitigating menopausal symptoms and offers various health benefits, including decreased risks of dementia and diabetes. Natural supplements like allulose and berberine can simulate GLP-1 effects, offering a less invasive path for improving metabolic health. For women's health, particularly during menopausal transitions, focus on resistance training, adequate protein intake, and ensuring gut health is emphasized by Dr. Carvo. The upcoming Metabolic Health Resort aims to provide a health-focused sanctuary for recovery and lifestyle change, free from processed food distractions. More About Dr. Charles Cavo: Dr. Charles Cavo is a distinguished leader in obesity medicine and women's health, with a particular focus on the metabolic challenges of perimenopause and menopause, such as weight gain and insulin resistance. With over 20 years as a board-certified OB/GYN and a decade of experience in bariatric medicine, Dr. Cavo is dedicated to delivering personalized, science-based care that empowers patients to take charge of their health. As the co-founder and Chief Medical Officer of Pounds Transformation, Dr. Cavo has helped countless individuals achieve their health and wellness goals through innovative, individualized approaches. His commitment to holistic care extends to his partnership with RENOVI Recovery, a cutting-edge metabolic recovery destination in the Dominican Republic, where he advances transformative solutions for metabolic health. Dr. Cavo's influence also spans the industry, serving as Chief Clinical Practitioner for RxSugar, a Scientific Board member for Avalon Globocare (creators of KetoAir), and a partner in Morphood AI and CT Women's Health. Featured in the Netflix documentary The Magic Pill, he combines his extensive expertise with a passion for education, innovation, and empowering lasting change. Website Instagram Connect with me!: Website Instagram Facebook YouTube

Alcohol and cancer, GLP-1 trial representativeness, diagnosing CAD, changing stroke rates in patients with AF, blanking periods after AF ablation are the topics John Mandrola, MD, covers this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Surgeon General Causes Hoopla Regarding ETOH Warning Dry January: Should Doctors Make It Year-Round? https://www.medscape.com/viewarticle/dry-january-should-doctors-make-it-year-round-2025a100009t Surgeon General Warning https://www.hhs.gov/about/news/2025/01/03/us-surgeon-general-issues-new-advisory-link-alcohol-cancer-risk.html GBD 2016 Collaboration Lancet https://doi.org/10.1016/S0140-6736(18)31310-2 RCT Voskobonik and colleagues https://www.nejm.org/doi/full/10.1056/NEJMoa1817591 Marcus and colleagues; UCSF https://pubmed.ncbi.nlm.nih.gov/33516710/ Review of ETOH AF https://doi.org/10.1016/j.jacc.2016.08.074 II. GLP-1 Agonists for Obesity –Trial vs Real World Generalizability of Trial Results https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2826335 HRS Document ICD http://dx.doi.org/10.1016/j.hrthm.2014.03.041 III. Stress Testing and CAD Severity Reynolds and colleagues. Observational ISCHEMIA Sub-analysis https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.123.013743 Foy Meta-analysis https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2655243 ISCHEMIA https://www.nejm.org/doi/full/10.1056/NEJMoa1915922 IV. Changing Stroke Rates with AF Teppo and colleagues. Finnish Study https://doi.org/10.1016/j.jacep.2024.10.029 Quinn and colleagues. https://www.ahajournals.org/doi/10.1161/circulationaha.116.024057 V. Patients' Lives Don't Pause for Blanking Periods Ruzieh and colleagues. https://doi.org/10.1016/j.ahjo.2024.100497 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

In this episode of the Active Life Podcast, Larry and Cody dive into their experience at Longevity Fest, a premier convention in Las Vegas focused on health, longevity, and wellness innovation. The event brought together over 3,000 medical professionals, thought leaders, and vendors showcasing cutting-edge advancements in health tech, supplements, and stress management solutions. Cody shares key observations from the vendor exhibits, highlighting trends like hyperbaric chambers, red light therapies, and unconventional IV treatments designed to optimize health and performance. The discussion takes a thought-provoking turn as Larry and Cody examine the industry's focus on symptom management versus addressing root causes. They reflect on the role of functional medicine and its synergy with fitness professionals to bridge the gap between medical treatment and long-term health improvements. Cody also shares his evolving perspective on popular weight-loss solutions like GLP-1 agonists, shedding light on the critical role of resistance training and proper nutrition for those using these therapies. The episode wraps up with actionable insights for fitness professionals looking to collaborate with healthcare providers. Cody emphasizes the importance of refining your message, building trust, and becoming the go-to expert that doctors can rely on to guide their patients toward sustainable exercise and health practices. Whether you're a coach, trainer, or wellness advocate, this episode offers valuable takeaways to elevate your practice. We help coaches build profitable careers by helping clients get out of aches and pains. Apply for a discovery call to see if AL-P is right for you:⁠ https://api.leadconnectorhq.com/widget/survey/JvANhoc8rTIUfFBASzCs

In this episode of What the Actual Fork, Sam and Jenna chat with Dr. Erin Knopf, a psychiatrist, pediatrician, and eating disorder specialist. They cover intuitive eating, the damaging effects of diet culture on families, and the use of medications like GLP-1 for weight loss in kids. Dr. Knopf shares insights on body diversity, children's growth patterns, and fostering a healthy relationship with food. She also introduces VERY, her virtual eating recovery practice, and highlights the importance of weight-inclusive care and challenging outdated medical biases. It's such an informative, empowering episode. Can't wait to hear what you think!Listen to more podcasts like this: https://wavepodcastnetwork.com/Follow:Dr. Erin Knopf:Instagram: @drerinknopfVERY: Virtual Eating Recovery for YouWebsite: very.healthInstagram: @virtual.eating.recovery4uControl Body Odor ANYWHERE with @lumedeodorant and get 15% off with promo code FORK at https://lumepodcast.com/FORK! #lumepodListen to more podcasts like this: https://wavepodcastnetwork.com/What The Actual Fork https://www.instagram.com/whattheactualforkpod/Sammy Previte https://www.instagram.com/find.food.freedom/Jenna Werner https://www.instagram.com/happystronghealthy.rd/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Drs. Karl and Spencer chat with Dr. Sowa about her book The Ozempic Revolution.Learn:Why she wrote the book.The top 3 things to know when starting a GLP-1 medicine.Also hear the top criticism from Drs. Karl and Spencer. You will laugh.Click here to get the bookIf you're on a GLP-1 currently and want to switch to Dr. Spencer's new clinic, Click Here

Midlife can feel like a whirlwind, can't it? But what if this stage of life is your chance to thrive, not just survive? In this episode, I chat with my dear friend Natalie Jill, a Midlife Expert who's helped thousands of women redefine what healthy aging really looks like. We get into her Thrive program and talk about becoming your own “health detective,” uncovering the real reasons behind what's holding you back from feeling your best.   Natalie and I get real about making decisions that truly align with the life you want. She shares her simple yet powerful tips for creating a vision of your future self and actually making it happen. We also touch on the magic of community and why having support can make all the difference. And you'll love the inspiring stories of women who've transformed their lives, including one who lost 40 pounds and found her spark again.   If you're feeling ready to take your next step, I've got two ways to support you! Try my Keto Green Shake—it's been a game-changer for boosting energy, curbing cravings, and feeling great every day (dranna.com/tryketoshake). And don't miss Natalie and me teaming up for the Thrive Masterclass at dranna.com/thrive. Let's uncover the keys to lasting fat loss and mindset shifts together.   Key Timestamps: [00:00] Introduction. [00:01:46] Mindset and fat loss principles. [00:04:09] Flexibility and sexuality connection. [00:10:03] Health detective in the aging process. [00:15:10] The power of decision-making. [00:18:19] The driving core motivator. [00:23:55] Vision and decision-making process. [00:30:00] Morning routine transformation. [00:40:51] Focusing on circumstances vs. action. [00:43:32] Leadership and health discipline. [00:47:37] GLP-1 and their effects. [00:50:14] The metabolic crisis. [00:52:28] Surgery vs. injectables in aesthetics. [00:56:02] Breast implant illness awareness.   Memorable Quotes: "In order to successfully continue to have health into our aging process as we get older, midlife and beyond, we have to learn how to be a health detective." [00:10:07] – Natalie Jill   "I'd want you to say, how are we going to shift? What do we need to focus on? Because staying in the story of what's wrong is never going to fix anything." [00:42:11] – Natalie Jill   Links Mentioned: Keto Green Shake: https://dranna.com/tryketoshake Thrive Masterclass: https://dranna.com/thrive   Connect with Natalie Jill: Instagram: https://www.instagram.com/nataliejillfit/ Facebook: https://www.facebook.com/nataliejillfit Twitter: https://x.com/nataliejillfit YouTube: https://www.youtube.com/nataliejillfitness   Connect with Dr. Anna Cabeca: Website: https://drannacabeca.com/pages/show Instagram: https://www.instagram.com/thegirlfrienddoctor/ YouTube: https://www.youtube.com/@thegirlfrienddoctor TikTok: https://www.tiktok.com/@drannacabeca   Produced by Evolved Podcasting: www.evolvedpodcasting.com

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sana announces beta cell transplantation without the need for immunosuppresion drugs, Modular Medical teams up with Nudge BG for a brand new completely closed-loop system, the FDA moves forward to crack down on compounded Ozempic and Mounjaro, Dexcom and Abbott bury the legal hatchett for a while, and more.  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:     Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Big news from Sana Biotechnology. Their first in human study of islet cells without any immunosuppression appears to be a success. This is very early and hasn't yet been peer reviewed and published.. but after four weeks, there were no safety issues and the transplanted beta cells were producing insulin. Sana's CEO says  “As far as we are aware, this is the first study showing survival of an allogeneic transplant with no immunosuppression or immune-protective device in a fully immune competent individual. Safe cell transplantation without immunosuppression has the potential to transform the treatment of type 1 diabetes and a number of other diseases.”   I've reached out to Sana to get more on this.. love to talk to them soon.   https://www.bakersfield.com/ap/news/sana-biotechnology-announces-positive-clinical-results-from-type-1-diabetes-study-of-islet-cell/article_d0390fd6-99cb-53bd-b04d-9337121e01bf.html XX FDA says no for sotagliflozin as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD).  Studies showed a meaningful reduction in A1C but a meaningful increase in DKA. The FDA first rejected this in 2019 and was resubmitted last summer. But The advisory committee voted 11 to 3 against the approval of sotagliflozin stating that the benefits of sotagliflozin do not outweight the risks in adults with T1D and CKD. Sotagliflozin is currently approved under the brand name Inpefa to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with 1) heart failure; or 2) type 2 diabetes mellitus, CKD, and other cardiovascular risk factors.  According to Lexicon, Inpefa will continue to be manufactured and made available to patients. https://www.renalandurologynews.com/news/fda-denies-approval-of-zynquista-for-type-1-diabetes-and-ckd/ XX Two companies we've been following are teaming up.. Modular Medical has an FDA clear patch pump and Nudge BG has an adaptive full closed loop. They've announced a new partnership agreement. From the release: Modular Medical's easy-to-use and cost-effective MODD1 insulin pump technology. Our combined system is intended to nudge blood glucose by making small changes to insulin delivery based on estimated glucose inputs from a continuous glucose monitor." Familiar name to some of you, Lane Desborough is the founder of Nudge BG. He says this will be a fully automated system, no mealtime bolusing needed.   https://www.accesswire.com/957703/modular-medical-announces-licensing-and-partnership-agreement-with-nudge-bg XX Beta Bionics filed for an initial public offering on Monday. The company did not disclose the number of shares it will offer or the price range. Beta Bionics plans for shares to be listed on the Nasdaq under the ticker symbol “BBNX.” The Irvine, California-based company makes an insulin pump called the iLet Bionic Pancreas, which was cleared by the Food and Drug Administration in 2023. Beta Bionics plans to use the proceeds to grow its sales and manufacturing infrastructure and develop new features for its device.   https://www.medtechdive.com/news/beta-bionics-insulin-pump-files-ipo/736805/     XX Tandem Diabetes Care, Inc. signed a multi-year collaboration agreement with the University of Virginia Center for Diabetes Technology (UVA) to advance research and development efforts on fully automated closed-loop insulin delivery systems.   There's a long history here – UVA is where the Control IQ algorithm was developed.  This agreement seems to keep the team together for another decade. https://www.businesswire.com/news/home/20250107162995/en/Tandem-Diabetes-Care-Enters-Multi-Year-Research-Collaboration-with-UVA-Center-for-Diabetes-Technology-for-Development-of-Advanced-Insulin-Delivery-Systems XX New study says insulin is still the best treatment for gestational diabetes, compared to oral glucose-lowering medications. Metformin and gluburide are being closely looked at since they're easier to administer, less costly, and have better acceptance among patients. But this study says insulin was a bit better – slight more babies were born larger for the metformin group, and more moms had hypoglycemia. https://www.medpagetoday.com/obgyn/pregnancy/113651 XX In its Citizen Petition to the FDA, Novo Nordisk argued that there is no clinical need to allow compounding for liraglutide, the type 2 diabetes injection it sells as Victoza. Novo Nordisk last month filed a Citizen Petition with the FDA asking the federal agency to exclude its type 2 diabetes injection Victoza (liraglutide) from a proposed list of drugs eligible for compounding. https://www.biospace.com/fda/novo-launches-citizen-petition-to-block-compounded-victoza XX Bit of an update on compounded terzepatide and semaglutide. The FDA is allowing a grace period of 60 days before starting to enforce the end of allowing compounds of Mounjaro. Meanwhile, semaglutide remains on the FDA's shortage list for several dose strengths, though all doses have been reported as “available” since late October 2024. Compounding pharmacies, especially larger 503B “outsourcing facilities,” maintain they provide an essential public service by offering lower-cost versions of medications that can cost over $1,000 per month. Many insurers still refuse to cover brand-name GLP-1 products for weight loss. Yet  the FDA has reported hundreds of adverse event reports allegedly linked to compounded versions of these drugs, which do not undergo the same rigorous manufacturing inspections and clinical testing as approved brands.   https://www.drugdiscoverytrends.com/compounders-and-drugmakers-clash-over-compounded-weight-loss-drugs-with-fda-in-the-middle/ XX Interesting story here.. this study says a fecal transplant can help people with type 1 and severe gastroenteropathy. The researchers say diabetic gastroenteropathy commonly affects individuals with type 1 diabetes, causing debilitating symptoms like nausea, vomiting, bloating, and diarrhea; however, treatment options remain limited. Researchers conducted a novel clinical trial to test the benefits of FMT in adult patients with type 1 diabetes and severe symptoms of gastroenteropathy, who were randomly assigned to receive either FMT or placebo capsules as the first intervention. After four weeks, Compared with placebo, FMT led to significant changes in the diversity of the gut microbiome. https://www.medscape.com/viewarticle/fmt-shows-early-success-type-1-diabetes-bowel-issues-2025a10000bg XX A couple of weeks ago, listeners told me that the Dexcom geofencing issue we reported on seems to be resolved. Dexcom is now confirming this. Previously, if you had an issue with Dexcom G7 outside of your home country, you couldn't reinstall or use the app without customer support. As of last month, the geofencing issue has now been resolved with the latest Dexcom G7 2.6 app update. Can I travel with my Dexcom G7? | Dexcom XX Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding patent disputes and not sue each other over patents for 10 years.   Dexcom and Abbott previously reached a settlement in 2014 related to their diabetes devices, which included a cross-licensing deal and an agreement not to sue each other until 2021. After that agreement expired, the companies filed a volley of patent lawsuits. https://www.medtechdive.com/news/abbott-dexcom-settle-cgm-patent-lawsuits/736300/  

MDJ Script 1-10-25.docx1 / 3MDJ Script/ Top Stories for January 10thPublish Date: January 10th Commercial:From the BG AD Group Studio, Welcome to the Marietta Daily Journal Podcast. Today is Friday, January 10th and Happy Birthday to Rod StewartI’m Peyton Spurlock and here are the stories Cobb is talking about, presented by Credit Union of Georgia. 1. Five presidents say goodbye to Jimmy Carter 2. GreyStone Power Ready to Respond to Winter Storm 3. AARP Georgia Now Accepting 2025 Community Challenge Grant Applications Plus, Leah McGrath from Ingles Markets on GLP-1 FoodsAll of this and more is coming up on the Marietta Daily Journal Podcast, and if you are looking for community news, we encourage you to listen and subscribe! BREAK: CU of GA (06.26.24 CU OF GA FREE CHECKING_REV_FINAL)STORY 1: Five presidents say goodbye to Jimmy CarterFormer President Jimmy Carter was honored at a service in Washington, D.C., attended by President Biden and all living ex-presidents. Carter, who passed away at 100, was praised for his forward-thinking leadership in human rights, conservation, and clean energy. The service concluded three days of tributes, including his lying in state at the U.S. Capitol. Eulogies highlighted his honesty and post-presidency humanitarian work, such as eradicating Guinea worm disease. After the service, Carter's remains were returned to Georgia for a private funeral, where he was to be buried beside his wife, Rosalynn.STORY 2: GreyStone Power Ready to Respond to Winter StormGreyStone Power, serving parts of south Cobb County, warned of a potential wintry mix, including snow and ice, from Jan. 10-11. The cooperative is prepared to address power outages, prioritizing repairs that restore service to the most members. Those with medical needs should have backup plans. During outages, avoid travel, but if necessary, carry a survival kit and report downed lines to 1-866-GREYSTONE. Members can report outages via text, app, or website. Generator users should follow safety guidelines to prevent backfeeding. GreyStone serves over 132,000 members across eight counties.STORY 3: AARP Georgia Now Accepting 2025 Community Challenge Grant Applications 2 / 3AARP Georgia is inviting eligible non-profits and governments to apply for the 2025 AARP Community Challenge grants, which fund projects to enhance community livability, especially for those aged 50 and older. The program, part of AARP's Livable Communities initiative, offers grants ranging from a few hundred to tens of thousands of dollars. This year, applications are open for capacity-building microgrants, demonstration grants, and flagship grants, focusing on areas like pedestrian safety, internet access, and housing. Since 2017, AARP has funded 1,700 projects with $20.1 million. Applications are due by March 5, with projects to be completed by December 15.We have opportunities for sponsors to get great engagement on these shows. Call 770.799.6810 for more info. We’ll be right back Break: DRAKE (Drake Realty (Cobb County)STORY 4: GaDOE Holds Multi-Agency Summit, Launches Attendance Dashboard and PSAThe Georgia Department of Education is launching initiatives to tackle chronic absenteeism, defined as students missing 10% or more of school days. With a current rate of 20.7%, GaDOE aims to improve attendance to enhance academic recovery post-pandemic. Efforts include a Multi-Agency Attendance Summit to foster collaboration, an Attendance Dashboard for real-time data analysis, and a public service announcement to raise awareness. Future plans involve using grant funds to support high-needs districts, partnering with UGA for statewide analysis, and offering professional learning opportunities. A webinar on the topic is scheduled for January 16.STORY 5: Upcoming Events at The Strand TheatreThe Earl and Rachel Smith Strand Theatre in Marietta has a diverse lineup of events, including the Indie Film Series showcasing independent films monthly, and a Fleetwood Mac tribute on Jan. 17. Other highlights include classic film screenings like "The Music Man" and "Casablanca," a tribute to The Everly Brothers, and a Taylor Swift tribute show. The theatre will also host jazz events, including a John Coltrane tribute and a jazz history talk series. Additionally, there will be performances like "A Comedy of Errors" and tributes to Elton John and Tom Petty. For more details, visit their website.Break:And now here is Leah McGrath from Ingles Markets on GLP-1 FoodsWe’ll have closing comments after this.Break: Ingles Markets 10Signoff- 3 / 3Thanks again for hanging out with us on today’s Marietta Daily Journal Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at mdjonline.comDid you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts.Produced by the BG Podcast NetworkShow Sponsors: ● www.ingles-markets.com ● www.cuofga.org ● www.drakerealty.com #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

In this episode, Dr. Rena Malik, MD, and Dr. Alexandra Sowa dive into the transformative effects of new obesity medications, highlighting dramatic weight loss results and their profound impact on personal and romantic relationships. They explore both the psychological and social dimensions, discussing increased libido, confidence, and potential emotional challenges such as resurfacing traumas. The conversation emphasizes the importance of muscle retention during weight loss, the need for strong support systems, and effective communication with partners. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments ▶️Chapters: 00:00:00 Introduction 00:02:34 Neurology rotation 00:03:06 Why weight loss is difficult? 00:07:49 Fasting glucoses 00:13:13 Hormonal influence 00:18:19 GLP-1 medications 00:28:58 Fear of weight of muscle loss 00:33:00 Emotional component to food 00:55:42 Food Packaging 00:57:25 Microdose Ozempic 01:00:56 Effect of Missing a Dose 01:08:35 GLP-1 friendly food 01:14:17 Non-negotiable things you should do Stay connected with Dr. Sowa on social media for daily insights and updates. Don't miss out—follow her now and check out these links! Dr. Sowa's Instagram - https://www.instagram.com/alexandrasowamd/?hl=en Get So Well by Dr. Sowa - https://www.instagram.com/getsowell/?hl=en The Ozempic Revolution by Dr. Sowa - https://www.amazon.com/Ozempic-Revolution-Doctors-Success-Yourself/dp/0063417006 Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices

CTL Script/ Top Stories of January 10th Publish Date: January 10th Pre-Roll: From the Ingles Studio Welcome to the Award-Winning Cherokee Tribune Ledger Podcast Today is Friday, January 10th and Happy Birthday to Rod Stewart I’m Peyton Spurlock and here are the stories Cherokee is talking about, presented by Credit Union of Georgia. 1. Holly Springs Police Arrest Florida Man Wanted for Exploiting Minors 2. U.S. House Passes Laken Riley Act 3. Cherokee County Middle Schooler Wins Regional Essay Contest Plus, Leah McGrath from Ingles Markets on GLP-1 Foods We’ll have all this and more coming up on the Cherokee Tribune-Ledger Podcast, and if you’re looking for Community news, we encourage you to listen and subscribe! Commercial: CU of GA (06.26.24 CU OF GA FREE CHECKING_REV_FINAL) STORY 1: Holly Springs Police Arrest Florida Man Wanted for Exploiting Minors Holly Springs police arrested Stephen Andrew Leedy, a Florida man charged with sexually exploiting minors and allegedly directing a girl to hang herself. On December 19, police acted on a notice regarding Leedy, wanted for child pornography and linked to a juvenile's death. After locating his vehicle, they arrested him and handed him over to the FBI. Leedy, a palliative care doctor, faces federal charges for producing child sexual abuse material and coercing minors into harmful acts. If convicted, he could face life in federal prison. STORY 2: U.S. House Passes Laken Riley Act The U.S. House of Representatives passed the Laken Riley Act, named after a Georgia murder victim, as its first act of the new Congress. The legislation mandates detention of illegal immigrants charged with nonviolent crimes. It passed 264-159, with support from 48 Democrats, including Rep. Lucy McBath. Laken Riley, a nursing student, was murdered by an illegal immigrant previously released after shoplifting charges. The case was highlighted by former President Trump during his campaign. The bill now faces a Republican-controlled Senate, needing some Democratic support to pass. STORY 3: Cherokee County Middle Schooler Wins Regional Essay Contest Arcadian Freund, an eighth-grader at E.T. Booth Middle School, won the Cherokee County award in the Metropolitan North Georgia Water Planning District's 23rd annual essay contest. Open to metro Atlanta middle schoolers, the contest invited essays on how water shapes the region, including topics like conservation and pollution control. Arcadian's essay emphasized protecting water resources and is available on the CCSD website. He, his family, and teacher Katie Imbriano attended the awards ceremony at the State Capitol. Arcadian will be recognized by the Cherokee County School Board on January 16. We have opportunities for sponsors to get great engagement on these shows. Call 770.874.3200 for more info. Back in a moment Break: Drake (Drake Realty (Cherokee County) STORY 4: Gas Station Coming to Buice Lake Parkway in Cherokee County A new gas station is set to be built in southwest Cherokee County after the Board of Commissioners approved an exceptional variance for SM Partner LLC. The station will be located at 820 Buice Lake Parkway near Acworth, despite opposition from residents concerned about traffic and light pollution. The site is part of the Buice Lake mixed-use development, zoned for commercial use. Commissioners emphasized the area's designation for commercial development and approved the plan with conditions, such as no drive-thru restaurants. The development includes 876 homes and 49,000 square feet of retail space. STORY 5: Janet Read Welch Sworn In as Cherokee School Board Chair Janet Read Welch was sworn in as the new chair of the Cherokee County school board, alongside re-elected members Kelly Poole and Patsy Jordan. Read Welch, previously a board member for 11 years, was elected chair unopposed. She expressed gratitude to supporters and emphasized her commitment to the district's success. Poole and Jordan, both re-elected without opposition, also expressed dedication to serving the district. The oath was administered by Judge Keith Wood, and Jordan was elected vice chair. A reception followed, celebrating with community members and school officials. Commercial: And now here is Leah McGrath from Ingles Markets on GLP-1 Foods We’ll have closing comments after this. COMMERCIAL: Ingles Markets 8 SIGN OFF – Thanks again for hanging out with us on today’s Cherokee Tribune Ledger Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at www.tribuneledgernews.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: · www.ingles-markets.com · www.drakerealty.com · cuofga.org #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversationsSee omnystudio.com/listener for privacy information.

On Friday's AOA, we kick off the show with a look at Farm Rescue's celebration of their 20th anniversary with Dan Erdmann, Director of Communications at Farm Rescue. In Segment Two, we take a look at the latest Meat Demand Monitor, a special report on the GLP-1 weight loss medication impact on meat demand and more with Dr. Glynn Tonsor from Kansas State University. (Find the reports online at https://www.agmanager.info)   In Segment Three, we take a look at how 2024 ended in the equipment markets and a look ahead to potential trends in 2025 with Andy Campbell, Director of Insights at Tractor Zoom. Then we close the show in Segment Four with a preview of Cattle Con 2025 in San Antonio, TX this February. Kristin Torres, NCBA  Executive Director of Meetings & Events joins us for the preview. Learn more at https://convention.ncba.org!

Dishin' Nutrition is back and is ready to take the New Year on with a bang! Sarah and Emma are talking about what the heck food noise is, GLP-1's, and intentionality behind wording around food. It's a worthwhile conversation that touches on a topic that many of us experience. Tune in now where you find your podcasts!

Reality TV Producer Carlos King is back! Craig speaks about his break up with Paige. RHONJ Jennifer Aydin has been fired from a housewives' gig for her horrific treatment of a Jersey Mike's employee. On RHOBH, Dorit realizes she may have been just a booty call. We want Lauren Sanchez! Carlos has scoop on RHOC Alexis Bellino. RHSLC is funny and Brownwyn's father/ husband will speak at the reunion. Carlos knows how to save New York and I agree! So funny and so juicy, enjoy! • Make this the year you take control of your debt. Get a free debt analysis right now at https://PDSDebt.com/juicyscoop It only takes thirty seconds!   • Head to https://acorns.com/juicyscoop or download the Acorns app to start saving and investing for your future today! • Now's your chance to change the way you sleep with Boll & Branch. Get 15% off, plus free shipping on your first set of sheets at https://BollAndBranch.com/juicyscoop Exclusions apply. See site for details. • For a limited time get 40% off your first box PLUS get a free item in every box for life. Go to https://Hungryroot.com/juicyscoop and use code juicyscoop  • Go to https://RO.CO/JUICYSCOOP to see if you qualify. Go to https://RO.CO/SAFETY for boxed warning and full safety information about GLP-1 medications. Stand Up Tickets and info: https://heathermcdonald.net/ Subscribe to Juicy Scoop with Heather McDonald on iTunes, the podcast app, and get extra juice on Patreon: https://bit.ly/JuicyScoopPodApple  https://www.patreon.com/juicyscoop  Shop Juicy Scoop Merch: https://juicyscoopshop.com  Follow Me on Social Media: Instagram: https://www/instagram.com/heathermcdonald  TikTok: https://www.tiktok.com/@heathermcdonald  Twitter: https://twitter.com/HeatherMcDonald Learn more about your ad choices. Visit podcastchoices.com/adchoices

With a staggering 181% increase in strength equipment usage between 2012 and 2022, as reported by Track My Gym, strength training has become the hottest trend in the fitness industry. In the first episode of the new season of the Fitness Business Podcast, host Justin Tamsett explores this trend with key expert Paul Byrne, as well as explores other key strategies with industry experts Jennifer Poljacik, David Steele, and Lauren Becker. The episode covers enhancing leadership, driving innovation, and boosting profits through developing a growth mindset, creating a strong culture, investing in team members, and leveraging technology to improve the member experience.   Key highlights from the episode: - Paul Byrne discusses the strength training trend and its implications for gym businesses. This trend is driven by social media, influencers, and changing consumer preferences. - Delivering exceptional customer service is crucial for gym businesses. Key strategies include defining service standards, understanding customer needs, and going the extra mile to create raving fans.  - Modern marketing in the fitness industry requires a shift from linear CRM processes to more organic and responsive interactions. Utilizing texting, AI, and retargeting ads can automate and speed up the marketing process, focusing on convenience, reviews, and ease of membership to attract and retain customers. Leave us a voicemail!   Our favorite quotable moments: “Consider making your gym [micro] influencer friendly. You have a room in the back where you have good lighting, you have the equipment you need. They can go back there and make it a place where they like to come and shoot their content.” - Paul Byrne “Creating the best customer experience can only benefit your bottom line and increase customer retention and staff satisfaction... One of the most helpful tools that I have used with my teams over the years is a wonderful book called Raving Fans by Ken Blanchard and Sheldon Bowles.” - Jennifer Poljacik "It's time to rethink the way we think of our prospects and how they interact with us, to get them from looking at us - to membership... We need to make it better." - David Steele   Resources: Fitness Business Podcast's LinkedIn CommunityMystery Shopping for Fitness Businesses - Website Paul Byrne - LinkedIn Harrison Co - Website Link to Strength Training Report - Access Here Link to GLP-1 Report - Access Here Merch Sponsor: GRIT Fitness - Website Be a Merch Sponsor - Here In The Trenches With A REXer: Jennifer Poljacik - LinkedIn 212 Fitness - Website and Facebook REX Roundtables - Website and Email Wise Words: David Steele - LinkedIn Sneeze It - Website Trusted Suppliers: Club Com - Website, LinkedIn, Instagram and TikTok Lauren Becker - LinkedIn Wellness Space - Website Solution One - Website Egym - Website   About Your Host: Justin “JT” Tamsett is a seasoned fitness industry veteran and passionate advocate for promoting physical activity. His mission is to reduce the health care costs across the globe by having more people move and move more often.  JT's hope is that his daughter Zoe can grow up in a world full of opportunity rather than one where governments and communities don't have the burden of an ageing and sickening population. With over 30 years of experience, JT has owned gyms, coached fitness classes, and now specialises in business coaching for fitness entrepreneurs.  Through his company, Active Management, JT provides guidance and support to gym owners worldwide, empowering them to build successful businesses and contribute to a healthier society. He also leads 8 REX Roundtables in the US and Australia, spoken at over 40 conferences in 23 countries, and consulted with gyms worldwide. JT's commitment to improving health extends beyond his professional endeavours, as he has also dedicated himself to coaching various sports and actively participates in industry organisations. Related: weight training, beginner weight lifting, weight lifting program, strength exercises, strength training for women, strength training for seniors, strength training for women over 50, strength training for beginners, training for women, workout for women, gym workout, weight training

In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, discusses key issues shaping the healthcare payer space in 2025, including the evolving coverage of GLP-1 medications, rising insurance costs, and the increasing fragmentation of provider-insurer relationships.

Subscriber-only episodeResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55If You are having issues accessing Paid Subscriber content please send an email to support@buzzsprout.com and a member of Buzzsprout's technical team will help you access the content.______________________________________________________________________The Provider Spotlight is a new bonus series of shorter episodes featuring doctors and specialists from past sessions—think of it as 'doctor shorts.' With over 25k scripts for Zepbound written weekly, many new subscribers haven't seen our earlier episodes, which helps them catch up quickly. Thanks for your support!On August 8th 2023 Dr Joy Bracey set down with the  The Plus SideZ Podcast to discuss the role GLP-1s can play in addictive behaviors such as over eating or alcohol. The Pharmaceutical industry is doing studies on this now.  Check out the full episode in Season one, episode 23 to hear Brenda's story. ______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy  Kim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

In this episode, I break down how GLP-1 drugs are already affecting consumer spending and what restaurants need to do to be prepared. I then focus on decision-making and how it can better your career, using real-world examples from those within the Line Cook Nation. From there, we discuss a NY Times article sharing nine food predictions for restaurants that I believe to be a very accurate assessment of what may come. LA Times Link: https://www.latimes.com/food/list/los-angeles-restaurants-providing-food-shelter-evacuees-first-responders-fire Eater LA Restaurants Link: https://www.eater.com/ NY Times Link: https://www.nytimes.com/2024/12/31/dining/food-eating-predictions-2025.html Food Dive Link: https://www.fooddive.com/news/glp-1-drug-use-cuts-grocery-spending-by-6-study-finds/736313/ CSP Link: https://www.cspdailynews.com/foodservice/circana-talks-profound-impact-glp-1-drugs-have-spending-food-beverages-more

GDP Script/ Top Stories for January 9th Publish Date: January 9th From the BG AD Group Studio Welcome to the Gwinnett Daily Post Podcast. Today is Thursday, January 9th and Happy birthday to Jimmy Page I’m Peyton Spurlock and here are your top stories presented by KIA Mall of Georgia. Gwinnett could get up to 3 inches of snow on Friday Lilburn police arrest suspect in New Year's Day double murder Apalachee High School student arrested for bringing gun to school this week Plus, Leah McGrath from Ingles Markets on GLP-1 Foods All of this and more is coming up on the Gwinnett Daily Post podcast, and if you are looking for community news, we encourage you to listen daily and subscribe! Break 1: 07.14.22 KIA MOG STORY 1: Gwinnett could get up to 3 inches of snow on Friday Metro Atlanta is expected to receive at least an inch of snow on Friday, with a Winter Storm Watch in effect from 7 a.m. Friday to 7 a.m. Saturday. The area could see up to 3 inches of snow and sleet, plus a quarter-inch of ice, while north Georgia may get 3 to 6 inches of snow. Governor Brian Kemp urged residents to prepare and stay informed. State offices will close Friday, with employees working remotely. The Georgia Department of Transportation is treating roads with brine and advises limiting travel from Friday morning to mid-day Saturday due to hazardous conditions. STORY 2: Lilburn police arrest suspect in New Year's Day double murder Lilburn police are investigating a double murder from New Year's Day, believed to be a domestic incident. An out-of-state caller prompted a welfare check, leading to a missing person's case that evolved into a homicide investigation. With assistance from Gwinnett and Duluth police, investigators worked through the night, discovering two crime scenes and identifying two bodies in Gwinnett County. A suspect was arrested 30 miles from Lilburn and charged with murder, but identities remain undisclosed pending family notification. Police credit the swift resolution to collaboration with Gwinnett and Duluth police departments. STORY 3: Apalachee High School student arrested for bringing gun to school this week A 14-year-old student at Apalachee High School was arrested for bringing a gun to school, four months after a previous shooting incident at the same school. The student was apprehended without incident and faces charges including possession of a firearm and theft. Classes were canceled for Thursday as a precaution. The arrest follows a tragic shooting on September 4, 2024, where Colt Gray killed four people and injured nine. This incident has prompted renewed discussions on school safety, with the Barrow County Board of Education holding a special session to address the issue. We have opportunities for sponsors to get great engagement on these shows. Call 770.874.3200 for more info. We’ll be right back Break 2: 08.05.24 OBITS_FINAL STORY 4: January Is National Blood Donor Month — Here's Where You Can Donate Winter weather and a busy cold and flu season often lead to American Red Cross blood drive cancellations, making early in the year a tough time for blood collection. The Red Cross urges donors, especially those with Type O negative blood and platelet donors, to donate to maintain the blood supply. Partnering with the NFL for National Blood Donor Month, donors before January 26 can enter to win a Super Bowl LIX package. Donation opportunities are available in Gwinnett County, including the Duluth Blood Donation Center. Visit the Red Cross website for more details and to schedule donations. STORY 5: Fulton Judge Throws Out Gwinnett's Challenge to Mulberry's Creation A Fulton County judge dismissed Gwinnett County's lawsuit against the creation of the City of Mulberry, rejecting claims that the legislation violated the Georgia Constitution. The dismissal allows Mulberry to proceed with its incorporation, which began on January 1. Despite multiple lawsuits challenging its creation, none have succeeded. Judge Rachelle Carnesale ruled that Gwinnett failed to qualify for declaratory relief, leading to the dismissal of related claims. Mulberry's mayor expressed eagerness to work with Gwinnett County on service transitions. Gwinnett officials consider the lawsuit pending and have not commented on the ruling. Break 3: And now here is Leah McGrath from Ingles Markets on GLP-1 Foods We’ll have closing comments after this Break 4: Ingles Markets 3 Signoff – Thanks again for hanging out with us on today’s Gwinnett Daily Post Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at www.gwinnettdailypost.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com www.wagesfuneralhome.com www.kiamallofga.com #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

Quest Nutrition might possess much more revenue diversification compared to when it was acquired more than five years ago, but that doesn't mean the Quest Bar has become any less of an important piece of the brand's multibillion-dollar growth puzzle today. In this latest episode, I'll utilize the Q1 2025 Simply Good Foods Company (NASDAQ: SMPL) earnings report, earnings call, and supplemental presentations that were filed on 1/8/2025 as the backdrop to provide broad nutritional snacking market insights. In fiscal Q1 2025, Atkins Nutritionals brand dragged down the overall portfolio performance, as Quest Nutrition beat categorical competitors in tracked channel retail takeaway (up 10% YoY). What's at the heart of the Quest Nutrition success? Quest Nutrition is still known for the original Quest Bar. And that means the company needs the bar business to be healthy for any of this innovation risk to make sense. But while Quest bar has positive growth, recent performance is lagging internal expectations a new protein bar innovation should launch in February called Quest Overload. Additionally, Quest Nutrition has proven it's one of the few brands that can successfully extend across multiple product forms...and its customer base expects them to come into an indulgent snacking category and flip it into great tasting (high protein, low sugar) offerings. The snacks segment of Quest Nutrition, which now accounts for almost half of all retail sales, saw retail takeaway growth increase 19%. But if we analyze one layer deeper…the salty side of the Quest snacks segment had quarterly retail takeaway growth of about 26%. Quest chips now represent about 25% of the total Quest Nutrition revenue and provide a substantial share of new users to the brand. And I've been a broken record when it comes to stating that salty snacks are where the excitement (and focus) should be placed within Quest Nutrition, but it's important to remember that any of this innovation risk only makes sense if the bar business continues to be healthy. So, while it was a higher proportion in 2019…the bar segment still accounts for about half of the total Quest Nutrition revenue. And that's why Quest Nutrition hasn't shied away from innovation (or renovation) activities over the recent years…from enrobed variants, mini sizes, revamping formulations, and now launching the “overload” bar platform. Also, I run through what's causing the weak brand performance at Atkins and explain actions the company is taking to change it…especially against the backdrop of GLP-1 weight loss solutions. In my opinion, you're going to see weight management brands like Atkins (and others) get repositioned on the right side of GLP-1 second-order effects through both product innovation (e.g. Atkins strong)...but most of the “innovation” will come in the targeted communication marketing strategies. Finally, OWYN had quarterly retail takeaway growth of 67% YoY. Based on revenue growth models, Simply Good Foods leadership expects OWYN fiscal 2025 net sales to be in the $135 million to $145 million range. FOLLOW ME ON MY SOCIAL MEDIA ACCOUNTS ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LINKEDIN⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YOUTUBE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TWITTER⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠FACEBOOK⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

About two years ago, we released a podcast with Dr. Thomas Wadden of the University of Pennsylvania describing work on a new generation of medications to treat diabetes and obesity. They were really taking the field by storm. Since then, much more is known since many additional studies have been published and so many people have been using the drugs. So many, in fact, the market value of the Danish company, Novo Nordisk, one of the two major companies selling the drugs, has gone up. It is now greater than the entire budget of the country of Denmark. This single company is responsible for about half of Denmark's economic expansion this year. So, a lot of people are now taking the drugs and this is a great time for an update on the drugs. And we're fortunate to have two of the world's leading experts join us: Dr. Wadden, Professor of Psychology and Psychiatry at the University of Pennsylvania School of Medicine and the inaugural Albert J. Stunkard Professor of Psychiatry at Penn. Joining us as well as Dr. Robert Kushner, a physician and professor of medicine at Northwestern University and a pioneer in testing treatments for obesity. Interview Summary Tom, you and I were colleagues at Penn decades ago. And I got frustrated the treatments for obesity didn't work very well. People tended to regain the weight. And I turned my attention to prevention and policy. But you hung in there and I admired you for that patience and persistence. And Bob, the same for you. You worked on this tenacious problem for many years. But for both of you, your patience has been rewarded with what seems to me to be a seismic shift in the way obesity and diabetes can be treated. Tom, I'll begin with you. Is this as big of a deal as it seems to me? Well, I think it is as big of a deal as it seems to you. These medications have had a huge impact on improving the treatment of type 2 diabetes, but particularly the management of obesity. With older medications, patients lost about 7 percent of their starting weight. If you weighed 200 pounds, you'd lose about 15 pounds. That was also true of our best diet and exercise programs. You would lose about 7 percent on those programs with rigorous effort. But with the new medications, patients are now losing about 15 to 20 percent of their starting body weight at approximately one year. And that's a 30-to-40-pound loss for a person who started at 200 pounds. And with these larger weight losses, we get larger improvements in health in terms of complications of obesity. So, to quote a good friend of mine, Bob Kushner, these medications have been a real game changer. Thanks for putting that in perspective. I mean, we're talking about not just little incremental changes in what treatments can produce, which is what we've seen for years. But just orders of magnitude of change, which is really nice to see. So, Bob what are these medications that we're talking about? What are the names of the drugs and how do they work? Well, Kelly, this transformation of obesity really came about by finding the target that is really highly effective for obesity. It's called the gut brain axis. And when it comes to the gut it's starting off with a naturally occurring gut hormone called GLP 1. I think everyone in the country's heard of GLP 1. It's released after we eat, and it helps the pancreas produce insulin, slows the stomach release of food, and reduces appetite. And that's where the obesity story comes in. So pharmaceutical companies have taken this hormone and synthesized it, something similar to GLP 1. It mimics the action of GLP 1. So, you could actually take it and give it back and have it injected so it augments or highlights this hormonal effect. Now, that same process of mimicking a hormone is used for another gut hormone called GIP that also reduces appetite. These two hormones are the backbone of the currently available medication. There's two on the market. One is called Semaglutide. That's a GLP 1 analog. Trade name is Wegovy. Now, it's also marketed for diabetes. Tom talked about how it is used for diabetes and increases insulin. That trade name is Ozempic. That's also familiar with everyone around the country. The other one that combined GLP 1 and GIP, these two gut hormones, so it's a dual agonist, the trade name for obesity is called Zep Bound, and the same compound for diabetes is called Mounjaro. These are terms that are becoming familiar, I think, to everyone in the country. Tom mentioned some about the, how much weight people lose on these drugs, but what sort of medical changes occur? Just to reiterate what Tom said, I'll say it in another way. For Semaglutide one third of individuals are losing 20 percent of their body weight in these trials. For Tirzepatide, it even outpaces that. And I got a third of individuals losing a quarter of their body weight. These are unheard of weight losses. And with these weight losses and these independent effects from weight, what we're seeing in the trials and in the clinic is that blood pressure goes down, blood sugar goes down, blood fats like triglyceride go down, inflammation in the body goes down, because we marked that with CRP, as well as improvement in quality of life, which we'll probably get to. But really interesting stuff is coming out over the past year or two or so, that it is improving the function of people living with congestive heart failure, a particular form called a preserved ejection fraction. We're seeing improvements in sleep apnea. Think of all the people who are on these CPAP machines every night. We're seeing significant improvements in the symptoms of sleep apnea and the apneic events. And lastly, a SELECT trial came out, that's what it was called, came out last year. Which for the very first time, Kelly, found improvements in cardiovascular disease, like having a heart attack, stroke, or dying of cardiovascular disease in people living with obesity and already have cardiovascular disease. That's called secondary prevention. That, Tom, is the game changer. Bob, I'd like to go back to Tom in a minute but let me ask you one clarifying question about what you just said. That's a remarkable array of biological medical benefits from these drugs. Just incredible. And the question is, are they all attributable to the weight loss or is there something else going on? Like if somebody lost equal amounts of weight by some other means, would these same changes be occurring? Those studies are still going on. It's very good. We're thinking it's a dual effect. It's the profound amount of weight loss, as Tom said. Fifteen to 21 to even 25 percent of average body weight. That is driving a lot of the benefits. But there also appear to be additional effects or weight independent effects that are working outside of that weight. We're seeing improvements in kidney function, improvement in heart disease, blood clotting, inflammation. And those are likely due to the gut hormone effect independent of the weight itself. That still needs to be sorted out. That's called a mitigation analysis where we try to separate out the effects of these drugs. And that work is still underway. Tom, one of the most vexing problems, over the decades that people have been working on treatments for obesity, has been long term results. And I'm curious about how long have people been followed on these drugs now? What are the results? And what was the picture before then? How do what we see now compared to what you saw before? The study that Bob just mentioned, the SELECT trial followed people for four years on Semaglutide. And patients achieve their maximal weight loss at about one year and they lost 10 percent of their weight. And when they were followed up at four years still on treatment, they still maintained a 10 percent weight loss. That 10 percent is smaller than in most of the trials, where it was a 15 percent loss. But Dr. Tim Garvey showed that his patients in a smaller trial lost about 15 percent at one year and while still on medication kept off the full 15 percent. I think part of the reason the weight loss in SELECT were smaller is because the study enrolled a lot of men. Men are losing less weight on this medication than women. But to your question about how these results compare to the results of earlier treatment, well with behavioral treatment, diet, and exercise back in the 70s beyond, people lost this 7 or 8 percent of weight. And then most people on average regain their weight over one to three years. And the same was true of medication. People often stopped these earlier medications after 6 to 12 months, in part because they're frustrated the losses weren't larger. Some people were also worried about the side effects. But the long and short is once you stop taking the medication, people would tend to regain their weight. And some of this weight regain may be attributable to people returning to their prior eating and activity habits. But one of the things we've learned over the past 20 years is that part of the weight regain seems to be attributable to changes in the body's metabolism. And you know that when you lose weight, you're resting metabolic rate, which is the number of calories your body burns at rest to maintain basic bodily functions. Your resting metabolic rate decreases by 10 to 15 percent. But also, your energy expenditure, the calories you burn during exercise decreases. And that may decrease by as much as 20 to 30 percent. So, people are left having to really watch their calories very carefully because of their lower calorie requirements in order to keep off their lost body weight. I think one thing these new drugs may do is to attenuate the drop both in resting metabolic rate and energy expenditure during physical activity. But the long and short of it is that if you stay on these new medications long term, you'll keep off your body weight. And you'll probably keep it off primarily because of improvements in your appetite, so you have less hunger. And as a result, you're eating less food. I'd like to come back to that in a minute. But let me ask a question. If a person loses weight, and then their body starts putting biological pressure on them to regain, how come? You know, it's disadvantageous for their survival and their health to have the excess weight. Why would the body do that? Well, our bodies evolved in an environment of food scarcity, and our physiology evolved to protect us against starvation. First, by allowing us to store body fat, a source of energy when food is not available. And second, the body's capacity to lower its metabolism, or the rate at which calories are burned to maintain these basic functions like body temperature and heart rate. That provided protection against food scarcity. But Kelly, you have described better than anybody else that these ancient genes that regulate energy expenditure and metabolism are now a terrible mismatch for an environment in which food is plentiful, high in calories, and available 24 by 7. The body evolved to protect us from starvation, but not from eating past our calorie needs. And so, it's this mismatch between our evolution and our appetite and our body regulation in the current, what you have called toxic food environment, when you can eat just all the time. I guess you could think about humans evolving over thousands of years and biology adapting to circumstances where food was uncertain and unpredictable. But this modern environment has happened really pretty rapidly and maybe evolution just hasn't had a chance to catch up. We're still existing with those ancient genes that are disadvantageous in this kind of environment. Bob back to the drugs. What are the side effects of the drugs? Kelly, they're primarily gastrointestinal. These are symptoms like nausea, diarrhea, constipation, heartburn, and vomiting. Not great, but they're generally considered mild to moderate, and temporary. And they primarily occur early during the first four to five months when the medications are slowly dose escalated. And we've learned, most importantly, how to mitigate or reduce those side effects to help people stay on the drug. Examples would be your prescriber would slow the dose escalation. So. if you're having some nausea at a particular dose, we wait another month or two. The other, very importantly, is we have found that diet significantly impacts these side effects. When we counsel patients on these medications, along with that comes recommendations for dietary changes, such as reducing fatty food and greasy food. Reducing the amount of food you're consuming. Planning your meals in advance. Keeping well hydrated. And very importantly, do not go out for a celebration or go out to meals on the day that you inject or at least the first two days. Because you're not going to tolerate the drug very well. We use that therapeutically. So, if you want to get control on the weekends, you may want to take your injection on a Friday. However, if weekends are your time out with friends and you want to socialize, don't take it on a Friday. Same thing comes with a personal trainer, by the way. If you're going to have a personal trainer on a Monday where he's going to overwork you, don't take the injection the day before. You'll likely be nauseated, you're not eating, you're not hydrating. So actually, there's a lot that goes into not only when to take the dose and how to take the dose, but how to take it to the best ability to tolerate it. Two questions based on what you said. One is you talked about these are possible side effects, but how common are they? I mean, how many people suffer from these? Well, the trials show about 25 to 45 percent or so of individuals actually say they have these symptoms. And again, we ask them mild, moderate, severe. Most of them are mild to moderate. Some of them linger. However, they really do peak during the dose escalation. So, working with your prescriber during that period of time closely, keeping contact with them on how to reduce those side effects and how you're doing out of medication is extremely important. And the second thing I wanted to ask related to that is I've heard that there's a rare but serious potential side effect around the issue of stomach paralysis. Can you tell us something about that? I mentioned earlier, Kelly, that these medications slow gastric emptying. That's pretty much in everybody. In some individuals who may be predisposed to this, they develop something called ileus, and that's the medical term for gastric paralysis. And that can happen in individuals, let's say who have a scleroderma, who have longstanding diabetes or other gastrointestinal problems where the stomach really stopped peristalsis. In other words, it's moving. That's typically presented by vomiting and really unable to move the food along. We really haven't seen much of that. We looked at the safety data in a SELECT trial that Tom mentioned, which was 17,000 individuals, about 8,000 or so in each group. We really did not see a significant increase in the ileus or what you're talking about in that patient population. Okay, thanks. Tom had alluded to this before, Bob, but I wanted to ask you. How do you think about these medicines? If somebody takes them, and then they stop using the medicines and they gain the weight back. Is that a sign that the medicine works or doesn't work? And is this the kind of a chronic use drug like you might take for blood pressure or cholesterol? That's a great way of setting up for that. And I like to frame it thinking of it as a chronic progressive disease, just like diabetes or hypertension. We know that when you have those conditions, asthma could be another one or inflammatory bowel disease, where you really take a medication long term to keep the disease or condition under control. And we are currently thinking of obesity as a chronic disease with dysfunctional appetite and fat that is deposited in other organs, causing medical problems and so on. If you think of it as a chronic disease, you would naturally start thinking of it, like others, that medication is used long term. However, obesity appeared to be different. And working with patients, they still have this sense 'that's my fault, I know I can do it, I don't want to be on medication for the rest of my life for this.' So, we have our work cut out for us. One thing I can say from the trials, and Tom knows this because he was involved in them. If we suddenly stop the medication, that's how these trials were definitely done, either blindly or not blindly, you suddenly stop the medication, most, if not all of the participants in these trials start to regain weight. However, in a clinical practice, that is not how we work. We don't stop medication suddenly with patients. We go slowly. We down dose the medication. We may change to another medication. We may use intermittent therapy. So that is work that's currently under development. We don't know exactly how to counsel patients regarding long term use of the medications. I think we need to double down on lifestyle modification and counseling that I'm sure Tom is going to get into. This is really work ahead of us, how to maintain medication, who needs to be on it long term, and how do we actually manage patients. Tom, you're the leading expert in the world on lifestyle change in the context of obesity management. I mean, thinking about what people do with their diet, their physical activity, what kind of thinking they have related to the weight loss. And you talked about that just a moment ago. Why can't one just count on the drugs to do their magic and not have to worry about these things? Well, first, I think you can count on the drugs to do a large part of the magic. And you may be surprised to hear me say that. But with our former behavioral treatments of diet and exercise, we spent a lot of time trying to help people identify how many calories they were consuming. And they did that by recording their food intake either in paper and pencil or with an app. And the whole focus of treatment was trying to help people achieve a 500 calorie a day deficit. That took a lot of work. These medications, just by virtue of turning down your appetite and turning down your responsiveness to the food environment, take away the need for a lot of that work, which is a real blessing. But the question that comes up is, okay, people are eating less food. But what are they eating? Do these medications help you eat a healthier diet with more fruits and vegetables, with lean protein? Do you migrate from a high fat, high sugar diet to a Mediterranean diet, or to a DASH like diet? And the answer is, we don't know. But obviously you would like people to migrate to a diet that's going to be healthier for you from a cardiovascular standpoint, from a cancer risk reduction standpoint. One of the principal things that people need to do on these medications is to make sure they get plenty of protein. And so, guidance is that you should have about 1 gram of dietary protein for every kilogram of body weight. If you're somebody who weighs 100 kilograms, you should get 100 grams of protein. And what you're doing is giving people a lot of dietary protein to prevent the loss of bodily protein during rapid weight loss. You did a [00:20:00] lot of research with me back in the 80s on very low-calorie diets, and that was the underpinning of treatment. Give people a lot of dietary protein, prevent the loss of bodily protein. The other side of the equation is just physical activity, and it's a very good question about whether these medications and the weight loss they induce will help people be more physically active. I think that they will. Nonetheless for most people, you need to plan an activity schedule where you adopt new activities, whether it's walking more or going to the gym. And one thing that could be particularly helpful is strength training, because strength training could mitigate some of the loss of muscle mass, which is likely to occur with these medications. So, there's still plenty to learn about what is the optimal lifestyle program, but I think people, if they want to be at optimal health will increase their physical activity and eat a diet of fruits and vegetables, leaner protein, and less ultra processed foods. Well, isn't it true that eating a healthy diet and being physically active have benefits beyond their impact on your ability to lose the weight? You're getting kind of this wonderful double benefit, aren't you? I believe that is true. I think you're going to find that there are independent benefits of being physical activity upon your cardiovascular health. There are independent benefits of the food that you're eating in terms of reducing the risk of heart attack and of cancer, which has become such a hot topic. So, yes how you exercise and what you eat makes a difference, even if you're losing weight. Well, plus there's probably the triple one, if you will, from the psychological benefit of doing those things, that you do those things, you feel virtuous, that helps you adhere better as you go forward, and these things all come together in a nice picture when they're working. Tom, let's talk more about the psychology of these things. You being a psychologist, you've spent a lot of time doing research on this topic. And of course, you've got a lot of clinical experience with people. So as people are losing weight and using these drugs, what do they experience? And I'm thinking particularly about a study you published recently, and Bob was a coauthor on that study that addressed mental health outcomes. What do people experience and what did you find in that study? I think the first things people experience is improvements in their physical function. That you do find as you've lost weight that you've got less pain in your knees, you've got more energy, it's easier to get up the stairs, it's easier to play with the children or the grandchildren. That goes a long way toward making people feel better in terms of their self-efficacy, their agency in the life. Big, big improvement there. And then, unquestionably, people when they're losing a lot of weight tend to feel better about their appearance in some cases. They're happy that they can buy what they consider to be more fashionable clothes. They get compliments from friends. So, all of those things are positive. I'm not sure that weight loss is going to change your personality per se, or change your temperament, but it is going to give you these physical benefits and some psychological benefits with it. We were happy to find in the study you mentioned that was conducted with Bob that when people are taking these medications, they don't appear to be at an increased risk of developing symptoms of depression or symptoms of suicidal ideation. There were some initial reports of concern about that, but the analysis of the randomized trials that we conducted on Semaglutide show that there is no greater likelihood of developing depression or sadness or suicidal ideation on the medication versus the placebo. And then the FDA and the European Medicines Agency have done a full review of all post marketing reports. So, reports coming from doctors and the experience with their patients. And in looking at those data the FDA and the European Medicines Agency have said, we don't find a causal link between these medications and suicidal ideation. With that said, it's still important that if you're somebody who's taking these medications and you start them, and all of a sudden you do feel depressed, or all of a sudden you do have thoughts like, maybe I'd be better off if I weren't alive any longer, you need to talk to your primary care doctor immediately. Because it is always possible somebody's having an idiosyncratic reaction to these medications. It's just as possible the person would have that reaction without being on a medication. You know, that, that can happen. People with overweight and obesity are at higher risk of depression and anxiety disorders. So, it's always going to be hard to tease apart what are the effects of a new medication versus what are just the effects of weight, excess weight, on your mood and wellbeing. You know, you made me think of something as you were just speaking. Some people may experience negative effects during weight loss, but overall, the effects are highly positive and people are feeling good about themselves. They're able to do more things. They fit in better clothes. They're getting good feedback from their environment and people they know. And then, of course, there's all the medical benefit that makes people feel better, both psychologically and physically. Yet there's still such a strong tendency for people to regain weight after they've lost. And it just reinforces the fact that, the point that you made earlier, that there are biological processes at work that govern weight and tendency to regain. And there really is no shame in taking the drug. I mean, if you have high blood pressure, there's no shame in taking the drug. Or high cholesterol or anything else, because there's a biological process going on that puts you at risk. The same thing occurs here, so I hope the de-shaming, obesity in the first place, and diabetes, of course, and then the use of these medications in particular might help more people get the benefits that is available for them. I recommend that people think about their weight as a biologically regulated event. Very much like your body temperature is a biologically regulated event, as is your blood pressure and your heart rate. And I will ask people to realize that there are genetic contributors to your body weight. just as there are to your height. If somebody says, I just feel so bad about being overweight I'll just talk with them about their family history of weight and see that it runs in the family. Then I'll talk to them about their height. Do you feel bad about being six feet tall, to a male? No, that's fine. Well, that that's not based upon your willpower. That's based upon your genes, which you received. And so, your weight, it's similarly based. And if we can use medications to help control weight, cholesterol, blood pressure, blood sugar, let's do that. It's just we live in a time where we're fortunate to have the ability to add medications to help people control health complications including weight. Bob, there are several of the drugs available. How does one think about picking between them? Well, you know, in an ideal medical encounter, the prescriber is going to take into consideration all the factors of prescribing a medication, like any other medication, diabetes, hypertension, you name the condition. Those are things like contraindication to use. What other medical problems does the patient have that may benefit the patient. Patient preferences, of course and side effects, safety, allergies, and then we have cost. And I'll tell you, Kelly, because of our current environment, it's this last factor, cost, that's the most dominant factor when it comes to prescribing medication. I'll have a patient walk in my room, I'll look at the electronic medical record, body mass index, medical problems. I already know in my head what is going to be the most effective medication. That's what we're talking about today. Unfortunately, I then look at the patient insurance, which is also on the electronic medical record, and I see something like Medicaid or Medicare. I already know that it's not going to be covered. It is really quite unfortunate but ideally all these factors go into consideration. Patients often come in and say, I've heard about Ozempic am I a candidate for it, when can I get it? And unfortunately, it's not that simple, of course. And those are types of decisions the prescriber goes through in order to come to a decision, called shared decision making with the patient. Bob, when I asked you the initial question about these drugs, you were mentioning the trade name drugs like Mounjaro and Ozempic and those are made by basically two big pharmaceutical companies, Novo Nordisk and Eli Lilly. But there are compounded versions of these that have hit the scene. Can you explain what that means and what are your thoughts about the use of those medications? So compounding is actually pretty commonly done. It's been approved by the FDA for quite some time. I think most people are familiar with the idea of compounding pharmacies when you have a child that must take a tablet in a liquid form. The pharmacy may compound it to adapt to the child. Or you have an allergy to an ingredient so the pharmacy will compound that same active ingredient so you can take it safely. It's been approved for long periods of time. Anytime a drug is deemed in shortage by the FDA, but in high need by the public, compounding of that trade drug is allowed. And that's exactly what happened with both Semaglutide and Tirzepatide. And of course, that led to this compounding frenzy across the country with telehealth partnering up with different compounding pharmacies. It's basically making this active ingredient. They get a recipe elsewhere, they don't get it from the company, they get this recipe and then they make the drug or compound it themselves, and then they can sell it at a lower cost. I think it's been helpful for people to get the drug at a lower cost. However, buyer beware, because not all compounded pharmacies are the same. The FDA does not closely regulate these compounded pharmacies regarding quality assurance, best practice, and so forth. You have to know where that drug is coming from. Kelly, it's worth noting that just last week, ZepBound and Mounjaro came off the shortage list. You no longer can compound that and I just read in the New York Times today or yesterday that the industry that supports compounding pharmacies is suing the FDA to allow them to continue to compound it. I'm not sure where that's going to go. I mean, Eli Lilly has made this drug. However, Wegovy still is in shortage and that one is still allowed to be compounded. Let's talk a little bit more about costs because this is such a big determinant of whether people use the drugs or not. Bob, you mentioned the high cost, but Tom, how much do the drugs cost and is there any way of predicting what Bob just mentioned with the FDA? If the compounded versions can't be used because there's no longer a shortage, will that decrease pressure on the companies to keep the main drug less expensive. I mean, how do you think that'll all work out? But I guess my main question is how much these things cost and what's covered by insurance? Well first how much do the drugs cost? They cost too much. Semaglutide, known in retail as Wegovy, is $1,300 a month if you do not have insurance that covers it. I believe that Tirzepatide, known as ZepBound, is about $1,000 a month if you don't have insurance that covers that. Both these drugs sometimes have coupons that bring the price down. But still, if you're going to be looking at out of pocket costs of $600 or $700 or $800 a month. Very few people can afford that. The people who most need these medications are people often who are coming from lower incomes. So, in terms of just the future of having these medications be affordable to people, I would hope we're going to see that insurance companies are going to cover them more frequently. I'm really waiting to see if Medicare is going to set the example and say, yes, we will cover these medications for anybody with a BMI of 40 or a BMI of 35 with comorbidities. At this point, Medicare says, we will only pay for this drug if you have a history of heart attack and stroke, because we know the drug is going to improve your life expectancy. But if you don't have that history, you don't qualify. I hope we'll see that. Medicaid actually does cover these medications in some states. It's a state-by-state variation. Short of that, I think we're going to have to have studies showing that people are on these medications for a long time, I mean, three to five years probably will be the window, that they do have a reduction in the expenses for other health expenditures. And as a result, insurers will see, yes, it makes sense to treat excess weight because I can save on the cost of type 2 diabetes or sleep apnea and the like. Some early studies I think that you brought to my attention say the drugs are not cost neutral in the short-term basis of one to two years. I think you're going to have to look longer term. Then I think that there should be competition in the marketplace. As more drugs come online, the drug prices should come down because more will be available. There'll be greater production. Semaglutide, the first drug was $1,300. Zepbound, the second drug Tirzepatide, $1,000. Maybe the third drug will be $800. Maybe the fourth will be $500. And they'll put pressure on each other. But I don't know that to be a fact. That's just my hope. Neither of you as an economist or, nor do you work with the companies that we're talking about. But you mentioned that the high cost puts them out of reach for almost everybody. Why does it make sense for the companies to charge so much then? I mean, wouldn't it make sense to cut the price in half or by two thirds? And then so many more people would use them that the company would up ahead in the long run. Explain that to me. That's what you would think, for sure. And I think that what's happened right now is that is a shortage of these drugs. They cannot produce enough of them. Part of that is the manufacturing of the injector pens that are used to dispense the drug to yourself. I know that Novo Nordisk is building more factories to address this. I assume that Lilly will do the same thing. I hope that over time we will have a larger supply that will allow more people to get on the medication and I hope that the price would come down. Of course, in the U. S. we pay the highest drug prices in the world. Fortunately, given some of the legislation passed, Medicare will be able to negotiate the prices of some of these drugs now. And I think they will negotiate on these drugs, and that would bring prices down across the board. Boy, you know, the companies have to make some pretty interesting decisions, don't they? Because you've alluded to the fact that there are new drugs coming down the road. I'm assuming some of those might be developed and made by companies other than the two that we're talking about. So, so investing in a whole new plant to make more of these things when you've got these competitor drugs coming down the road are some interesting business issues. And that's not really the topic of what we're going to talk about, but it leads to my final question that I wanted to ask both of you. What do you think the future will bring? And what do you see in terms of the pipeline? What will people be doing a year from now or 2 or 5? And, you know, it's hard to have a crystal ball with this, but you two have been, you know, really pioneers and experts on this for many years. You better than anybody probably can answer this question. Bob, let me start with you. What do you think the future will bring? Well, Kelly, I previously mentioned that we finally have this new therapeutic target called the gut brain axis that we didn't know about. And that has really ushered in a whole new range of potential medications. And we're really only at the beginning of this transformation. So not only do we have this GLP 1 and GIP, we have other gut hormones that are also effective not only for weight loss, but other beneficial effects in the body, which will become household names, probably called amylin and glucagon that joins GLP 1. And we not only have these monotherapies like GLP 1 alone, we are now getting triagonists. So, we've got GIP, GLP 1, and glucagon together, which is even amplifying the effect even further. We are also developing oral forms of GLP 1 that in the future you could presumably take a tablet once a day, which will also help bring the cost down significantly and make it more available for individuals. We also have a new generation of medications being developed which is muscle sparing. Tom talked about the importance of being strong and physical function. And with the loss of lean body mass, which occurs with any time you lose weight, you can also lose muscle mass. There's drugs that are also going in that direction. But lastly, let me mention, Kelly, I spend a lot of my time in education. I think the exciting breakthroughs will not be meaningful to the patient unless the professional, the provider and the patient are able to have a nonjudgmental informative discussion during the encounter without stigma, without bias. Talk about the continuum of care available for you, someone living with obesity, and get the medications to the patient. Without that, medications over really sit on the shelf. And we have a lot of more work to do in that area. You know, among the many reasons I admire the both of you is that you've, you've paid a lot of attention to that issue that you just mentioned. You know, what it's like to live with obesity and what people are experiencing and how the stigma and the discrimination can just have devastating consequences. The fact that you're sensitive to those issues and that you're pushing to de-stigmatize these conditions among the general public, but also health care professionals, is really going to be a valuable advance. Thank you for that sensitivity. Tom, what do you think? If you appear into the crystal ball? What does it look like? I would have to agree with Bob that we're going to have so many different medications that we will be able to combine together that we're going to see that it's more than possible to achieve weight losses of 25 to 30 percent of initial body weight. Which is just astonishing to think that pharmaceuticals will be able to achieve what you achieve now with bariatric surgery. I think that it's just, just an extraordinary development. Just so pleased to be able to participate in the development of these drugs at this stage of career. I still see a concern, though, about the stigmatization of weight loss medications. I think we're going to need an enormous dose of medical education to help doctors realize that obesity is a disease. It's a different disease than some of the illnesses that you treat because, yes, it is so influenced by the environment. And if we could change the environment, as you've argued so eloquently, we could control a lot of the cases of overweight and obesity. But we've been unable to control the environment. Now we're taking a course that we have medications to control it. And so, let's use those medications just as we use medications to treat diabetes. We could control diabetes if the food environment was better. A lot of medical education to get doctors on board to say, yes, this is a disease that deserves to be treated with medication they will share that with their patients. They will reassure their patients that the drugs are safe. And that they're going to be safe long term for you to take. And then I hope that society as a whole will pick up that message that, yes, obesity and overweight are diseases that deserve to be treated the same way we treat other chronic illnesses. That's a tall order, but I think we're moving in that direction. BIOS Robert Kushner is Professor of Medicine and Medical Education at Northwestern University Feinberg School of Medicine, and Director of the Center for Lifestyle Medicine in Chicago, IL, USA. After finishing a residency in Internal Medicine at Northwestern University, he went on to complete a post-graduate fellowship in Clinical Nutrition and earned a Master's degree in Clinical Nutrition and Nutritional Biology from the University of Chicago. Dr. Kushner is past-President of The Obesity Society (TOS), the American Society for Parenteral and Enteral Nutrition (ASPEN), the American Board of Physician Nutrition Specialists (ABPNS), past-Chair of the American Board of Obesity Medicine (ABOM), and Co-Editor of Current Obesity Reports. He was awarded the ‘2016 Clinician-of-the-Year Award' by The Obesity Society and John X. Thomas Best Teachers of Feinberg Award at Northwestern University Feinberg School of Medicine in 2017. Dr. Kushner has authored over 250 original articles, reviews, books and book chapters covering medical nutrition, medical nutrition education, and obesity, and is an internationally recognized expert on the care of patients who are overweight or obese. He is author/editor of multiple books including Dr. Kushner's Personality Type Diet (St. Martin's Griffin Press, 2003; iuniverse, 2008), Fitness Unleashed (Three Rivers Press, 2006), Counseling Overweight Adults: The Lifestyle Patterns Approach and Tool Kit (Academy of Nutrition and Dietetics, 2009) and editor of the American Medical Association's (AMA) Assessment and Management of Adult Obesity: A Primer for Physicians (2003). Current books include Practical Manual of Clinical Obesity (Wiley-Blackwell, 2013), Treatment of the Obese Patient, 2nd Edition (Springer, 2014), Nutrition and Bariatric Surgery (CRC Press, 2015), Lifestyle Medicine: A Manual for Clinical Practice (Springer, 2016), and Obesity Medicine, Medical Clinics of North America (Elsevier, 2018). He is author of the upcoming book, Six Factors to Fit: Weight Loss that Works for You! (Academy of Nutrition and Dietetics, December, 2019). Thomas A. Wadden is a clinical psychologist and educator who is known for his research on the treatment of obesity by methods that include lifestyle modification, pharmacotherapy, and bariatric surgery. He is the Albert J. Stunkard Professor of Psychology in Psychiatry at the Perelman School of Medicine at the University of Pennsylvania and former director of the university's Center for Weight and Eating Disorders. He also is visiting professor of psychology at Haverford College. Wadden has published more than 550 peer-reviewed scientific papers and abstracts, as well as 7 edited books. Over the course of his career, he has served on expert panels for the National Institutes of Health, the Federal Trade Commission, the Department of Veterans Affairs, and the U.S. House of Representatives. His research has been recognized by awards from several organizations including the Association for the Advancement of Behavior Therapy and The Obesity Society. Wadden is a fellow of the Academy of Behavioral Medicine Research, the College of Physicians of Philadelphia, the Obesity Society, and Society of Behavioral Medicine. In 2015, the Obesity Society created the Thomas A. Wadden Award for Distinguished Mentorship, recognizing his education of scientists and practitioners in the field of obesity.

GLP-1 medications are everywhere—on your FYPs, on the evening news, and, as JVN shares, in your own weekly routine. But what do these drugs really do? In this no-holds-barred conversation with Dr. Terry Simpson, a surgeon and culinary medicine expert, JVN dives deep into the science, the side effects, and the cultural firestorm surrounding GLP-1s like Ozempic. Are they the future of weight loss and metabolic health—or just another wellness trend? Trigger Warning: This episode contains discussions about eating disorders, body image, and weight loss medications. Please listen with care. Dr. Terry Simpson, MD is a physician, research scientist, weight loss surgeon, cook, author, dad, and a proponent for healthy eating. "And not in that order.” He received his undergraduate, graduate, and medical degrees from The University of Chicago. When he became a fellow of the American College of Surgeons he was the 22nd Native American to become a surgeon and the first Alaska Native to become one. He was the first surgeon to be certified in the field of Culinary Medicine - which means not only is he up to date with the latest nutrition research but he can cook too! When not in clinic, you'll find him on social media with more than 1 million followers, battling medical misinformation, inspiring healthy habits. You can find Dr. Terry Simpson on Instagram @drterrysimpsonmd and TikTok @drterrrysimpson Follow us on Instagram @CuriousWithJVN to join the conversation. Jonathan is on Instagram @JVN. Transcripts for each episode are available at JonathanVanNess.com. Find books from Getting Curious guests at bookshop.org/shop/curiouswithjvn. Our senior producers are Chris McClure and Julia Melfi. Our associate producer is Allison Weiss. Our engineer is Nathanael McClure. Production support from Julie Carrillo, Anne Currie, and Chad Hall. Our theme music is “Freak” by QUIÑ; for more, head to TheQuinCat.com. Curious about bringing your brand to life on the show? Email podcastadsales@sonymusic.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Stassi and C-O-Lo are kicking off 2025 with some major New Year's energy! After a long break with her kids, she's feeling emotional about Hartford growing up—especially now that her daughter lives in her Elphaba outfit and has her contemplating a Frozen-meets-Wicked birthday party mashup. Stassi is on a mission to find her word of the year, taking inspo from Meghan Markle's resilience, and spilling on how she's tackling social anxiety as part of her New Year's goals.  Plus, she's narrowing down her signature scent and embracing her forever love for Castlecore (she was into it before it was trendy). New year, new magic, and all the energy focused on manifesting positivity! This episode is sponsored by: Lume -Control Body Odor ANYWHERE with @lumedeodorant and get 15% off with promo code Stassi at Lumepodcast.com/Stassi ! #lumepod. OUAI - Go to THEOUAI.com and use code STASSI for 15% off any product. RO - Go to RO.CO/STASSI to see if your insurance covers GLP-1s—for free. Hiya - Receive 50% off your first order at hiyahealth.com/STASSI. Our Place - Go to fromourplace.com and enter my code STASSI at checkout to receive 10% off sitewide. Progressive - Visit Progressive.com to see if you could save on car insurance.

In this episode of Quah (Q & A), Sal, Adam & Justin coach four Pump Heads via Zoom. Mind Pump Fit Tip: Are you measuring your progress with the mirror and scale? You WILL fail! DO THIS instead. (2:26) The strength benefits of dietary cholesterol. (18:15) Addressing the egg shortage. (22:17) The GLP-1 phenomenon continues to explode. (28:55) The illusion of freedom. (32:14) Being proactive vs reactive when it comes to a cold. (36:45) Terrible health trends of the past. (40:22) Prenatal nutrition and your face shape. (45:56) Red-light therapy and improvement in eyesight. (49:53) If you could live forever, would you? (50:57) Washing away at sea. (52:57) #ListenerLive question #1 – Any help or guidance on a 69-year-old wanting to get on stage? (58:23) #ListenerLive question #2 – How can I roll out a strength-based workout for our Star Wars Fanclub? (1:20:41) #ListenerLive question #3 – When do you breathe during the exercises? (1:31:23) #ListenerLive question #4 – Any suggestions on how to be a strong, fit 56-year-old, and rock the Mother Of the Bride look? (1:39:37) Related Links/Products Mentioned Ask a question to Mind Pump, live! Email: live@mindpumpmedia.com Visit Joovv for an exclusive offer for Mind Pump listeners! ** Code MINDPUMP to get $50 off your first purchase. ** Visit NED for an exclusive offer for Mind Pump listeners! ** Code MINDPUMP at checkout for 20% off ** January Promotion: New Year's Resolutions Special Offers (New to Weightlifting Bundle | Body Transformation Bundle | New Year Extreme Intensity Bundle | Body Transformation Bundle 2.0  ** Savings up to $350! ** Mind Pump #2320: Throw Away the Scale! Effect of Dietary Cholesterol on Muscle Hypertrophy with Resistance Training Nestlé's GLP-1 push takes in protein shots - Yahoo Finance Skincare trends of the past: toxic and sometimes fatal How Mom's Pregnancy Diet Affects Your Facial Features Does Red Light Therapy Help Your Eyes for Macular Degeneration? Don't Die: The Man Who Wants to Live Forever - Netflix Santa Cruz Wharf collapse: 3 rescued after pier falls into ocean Visit Hiya for an exclusive offer for Mind Pump listeners! ** Receive 50% off your first order ** Train the Trainer Webinar Series Mind Pump #2480: Your Blueprint for Single-Digit Body Fat MAPS Prime Pro Webinar How Do I Choose The Right Weight? (LIFT RESPONSIBLY) – YouTube The Best Way to Breathe For Maximum Power & Strength (Ben Pollack) | MIND PUM Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Bryan Johnson (@bryanjohnson_) Instagram  

Why are dalmatians often associated with firefighters and fire trucks? Is it just a mascot thing or is there more to the story? Of course, there is more to the story and this episode begins with a quick explanation. https://www.livescience.com/33293-dalmatians-official-firehouse-dogs.html The world is full of optimists and pessimists. Which is better? How do we come to be one or the other – are we born that way? What does it mean to be an optimist and are there benefits to it? These things I explore with my guest Sumit Paul-Choudhury. He is the former Editor-in-Chief of New Scientist; he trained as an astrophysicist and has worked as a financial journalist. He is also author of the book The Bright Side: How Optimists Change the World, and How You Can Be One (https://amzn.to/3W3Ndzl). Have you ever NOT spoken up at a meeting because it is just easier to go along with the crowd – even when you know you were right? It seems we have been taught that compliance and being a team player is best while defying the consensus is bad. Well maybe not. There is another way to look at this, which is why Dr. Sunita Shah is here. She believes saying no and defying conventional wisdom is often the right thing to do. And you can do it in a way that doesn't offend. Sunita is an award-winning professor at Cornell University and an expert in organizational psychology. She is author of the book Defy: The Power of No in a World That Demands Yes (https://amzn.to/49Zecln)  Keeping warm in the winter cold can be tricky and expensive. Listen as I offer some easy and practical ideas that will help keep everyone in your home nice and warm without having to turn up the heat and run up the bill. https://www.thespruce.com/ways-to-keep-warm-without-turning-up-the-heat-1388206 PLEASE SUPPORT OUR SPONSORS!!! SHOPIFY:  "Established in 2025". Has a nice ring to it, doesn't it? Sign up for a $1 per-month trial period at https://Shopify.com/sysk . Go to SHOPIFY.com/sysk to grow your business! HERS: Hers is changing women's healthcare by providing access to GLP-1 weekly injections with the same active ingredient as Ozempic and Wegovy, as well as oral medication kits. Start your free online visit today at https://forhers.com/sysk Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 2590 - On this Wednesday's show, Vinnie Tortorich and Chris Shaffer share a talk about GLP-1s and how you don't know what you don't know, and more. https://vinnietortorich.com/2025/01/you-dont-know-what-you-dont-know-episode-2590 PLEASE SUPPORT OUR SPONSORS YOU CAN WATCH ALL THE PODCAST EPISODES ON YOUTUBE - You Don't Know What You Don't Know Vinnie had an idea for a particular gym in his early years in Los Angeles. (2:00) Chris' goals this year. (10:00) Vinnie has a namesake! (15:00) Recent guest Joseph Raney (episode 2581, “Doing The Right Thing”) and his beautiful wife have a new baby, and he is named after Vinnie. Chris asks Vinnie's thoughts about the high percentage of people going on GLP-1s. (20:00) Time has shown that several predictions Vinnie has made over the years have been revealed to be on point. He is right about the effects of GLP-1s; the side effects will not be worth it. Muscle wasting, loose stools, constipation, and “bounce back” weight gain once off the drug are just the beginning. (36:00) More serious ones are obstructed bowel and gastroparesis (paralyzed intestines, so food doesn't pass through). There is muscle wasting, but don't forget, your heart is a muscle, too. When you regularly eat a lot of carbs, you don't realize how much of your brain fog, aches, pains, etc. are related. It becomes your “normal,” and you don't know what you don't know. Anna and Vinnie will be at Bold Fork Books in Washington, DC, on January 15, 2025. (52:00)  Here is a link to the event: If you are interested in the NSNG® VIP group, it's OPEN for all your New Year's motivation and accountability at More News Don't forget to check out Serena Scott Thomas on Days Of Our Lives on the Peacock channel.  “Dirty Keto” is finally available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook is available!  You can go to You can order it from . Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day! There's a new NSNG® Foods promo code you can use! The promo code ONLY works on the NSNG® Foods website, NOT on Amazon. https://nsngfoods.com/ [the_ad id="20253"] PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere: REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: